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ABSTRACT 
Age-related cataract is a clouding of the lens that leads to decreased vision. It increases with 
age and is one of the leading causes of blindness worldwide. The only treatment currently 
available is surgery. Therefore, it is important to identify modifiable risk factors for cataract 
prevention. The cause of cataract is not fully understood and may be multifactorial, involving 
oxidative stress, a condition of disrupted balance between oxidants and antioxidants. 
Oxidative damage to lens proteins and lipids is suggested to be involved in the development 
of cataract. Antioxidants may protect against oxidative damage.   
 
The aim of this thesis was to examine factors related to oxidative stress, including biomarkers 
of exogenous/dietary and endogenous antioxidants, and systemic oxidative stress and 
inflammation, as well as vitamin supplement use and physical activity, with the risk of age-
related cataract. The studies were based on women and men, born 1914-1952, in the 
population-based Swedish Mammography Cohort and the Cohort of Swedish Men. 
Information on diet and lifestyle factors was obtained from a self-administered questionnaire 
at baseline. Cases of age-related cataract were identified through linkage to registers. 
 
The relationship between exogenous/dietary and endogenous antioxidants was examined in a 
cross-sectional study of women with and without a history of chronic diseases. High fruit and 
vegetable intake and high levels of plasma carotenoids were associated with lower plasma 
extracellular superoxide dismutase activity (an endogenous antioxidant enzyme) in healthy 
women but not in women with a history of chronic diseases. In a nested case-control study 
including women with and without incident cataract, higher levels of urinary 8-iso-
prostaglandin F2α (a biomarker for systemic oxidative stress) were associated with increased 
risk of cataract, but no association was observed for 15-keto-dihydro-prostaglandin F2α (a 
biomarker for systemic inflammation). The association between dietary supplement use and 
risk of cataract was investigated prospectively in the cohorts. The use of single, high-dose 
supplements of vitamin C or E, as well as B vitamins, but not multivitamins (usually 
containing vitamin doses close to recommended daily intake), was associated with increased 
risk of cataract. The use of vitamin C supplements in combination with some oxidative stress-
related factors, such as age and corticosteroid use, as well as in the long-term, may be 
associated with even higher risk. The association between physical activity and risk of 
cataract was also examined prospectively. Higher levels of total physical activity, especially 
long-term, and specific subtypes including walking/bicycling and work/occupational activity, 
were associated with lower risk of cataract in women and men. Conversely, high leisure time 
inactivity levels were associated with increased risk of cataract.  
 
In conclusion, these results suggest that maintaining low systemic oxidative stress by having 
a healthier lifestyle, including eating a diet rich in antioxidants instead of taking high-dose 
supplements and being physically active may prevent cataract development in the general 
population.  
POPULÄRVETENSKAPLIG SAMMANFATTNING 
Oxidativ stress är ett tillstånd som uppstår vid obalans mellan oxidanter och antioxidanter, 
där det bildas ett överskott av oxidanter eller finns otillräckligt med antioxidantaktivitet. 
Reaktiva syre- och kväveföreningar bildas vid olika cellulära processer, som t ex 
cellsignalering och cellmetabolism, men för stora mängder av dessa oxidanter kan leda till 
oxidativa skador på lipider, protein och DNA. Antioxidanter, både de som tillförs via 
kosten och kroppsegna, behövs för att skydda cellerna mot oxidativa skador. Oxidativ stress 
har associerats med åldrandet och olika sjukdomar som t ex grå starr. Åldersberoende grå 
starr är en vanlig ögonsjukdom som drabbar många äldre. Det innebär att ögats lins 
grumlas, vilket leder till nedsatt syn. Linsen utsätts dagligen för oxidation och det är därför 
viktigt att ha ett effektivt och välfungerande antioxidantsystem för att skydda ögat mot 
oxidativa skador. Orsaken till varför grå starr uppstår är idag inte fullständigt klarlagt, men 
en viktig del anses involvera oxidativ stress. Idag är den enda behandlingen att ersätta den 
grumliga linsen med en konstgjord lins genom operation. I Sverige är gråstarrsoperation 
den vanligast utförda operationen och enligt Nationella Kataraktregistrets senaste årsrapport 
utfördes ca 110,000 operationer under 2013. Det är därför viktigt att studera både 
skyddande faktorer och riskfaktorer för grå starr för att kunna förebygga uppkomsten av 
sjukdomen.   
 
Syftet med denna avhandling var att studera sambanden mellan olika antioxidanter, samt 
hur faktorer relaterade till oxidativ stress, såsom biomarkörer för systemisk oxidativ stress 
och inflammation, samt vitamintillskott och fysisk aktivitet, påverkar risken för 
åldersberoende grå starr. Studierna i avhandlingen är baserade på kvinnor och män, 45-83 
år, från de populationsbaserade kohorterna Svenska mammografikohorten (inklusive den 
kliniska subkohorten) som startades 1987 och Kohorten av svenska män som startades 
1997. Deltagarna har vid start av studien besvarat ett frågeformulär med frågor relaterade 
till kost och livsstilsvanor. Kvinnorna i den kliniska subkohorten besvarade ytterligare ett 
frågeformulär samt deltog i en hälsoundersökning där de lämnade blod- och urinprover. 
Information om gråstarrsoperationer erhölls genom matchning mot olika register. 
   
I det första delarbetet undersökte vi i en tvärsnittsstudie sambandet mellan antioxidanter 
från kosten (frukt- och grönsaksintag och karotenoider i blodet) och kroppsegna 
antioxidanter (plasma extracellulär superoxiddismutas-aktivitet, vilket är ett antioxidant 
enzym som produceras i kroppen och katalyserar oskadliggörande av superoxid som är en 
reaktiv syreförening) hos friska kvinnor och kvinnor med kroniska sjukdomar. Resultaten 
visade att friska kvinnor med ett högt intag av frukt och grönsaker samt höga nivåer av 
karotenoider i blodet hade lägre plasma superoxiddismutas-aktivitet. Det skulle kunna bero 
på en kompensatorisk nedreglering av kroppsegna antioxidanter vid högt antioxidantintag 
från kosten. Vi observerade däremot inget samband hos kvinnor med kroniska sjukdomar, 
såsom hjärt-kärlsjukdomar, diabetes eller cancer.  
 
  
I det andra delarbetet studerade vi biomarkörer för systemisk oxidativ stress (8-iso-
prostaglandin F2α) och inflammation (15-keto-dihydro-prostaglandin F2α) i urin hos kvinnor 
med och utan grå starr. För varje kvinna som hade utvecklat grå starr under 
uppföljningstiden 2003-2009 slumpades en frisk kontroll som matchats för ålder och datum 
för inlämning av urinprov. Kvinnor med grå starr hade högre 8-iso-prostaglandin F2α nivåer 
(systemisk oxidativ stress) jämfört med friska kontroller. Däremot observerades ingen 
skillnad i nivåer av 15-keto-dihydro-prostaglandin F2α (systemisk inflammation). 
 
Resultaten från kohortstudierna i det tredje och fjärde delarbetet visade att män som 
använde enbart vitamin C eller vitamin E kosttillskott innehållande höga doser, men inte de 
som använde multivitaminer (vanligtvis innehållande flera vitaminer och/eller mineraler 
med doser nära det rekommenderade dagliga intaget), hade ökad risk för grå starr jämfört 
med de som inte använde kosttillskott. För vitamin C kosttillskott verkade sambandet vara 
starkare bland äldre män, kortikosteroid-användare och långtidsanvändare. Dessa resultat 
bekräftar en tidigare publicerad studie baserat på den Svenska Mammografikohorten som 
visade liknande resultat. Användning av kosttillskott innehållande höga doser av olika B 
vitaminer var också kopplat till ökad risk för grå starr hos kvinnor och män.  
  
I det femte delarbetet undersökte vi i en kohortstudie sambandet mellan fysisk aktivitet och 
risk för grå starr hos kvinnor och män. Resultaten visade att de som hade hög total fysisk 
aktivitet, promenerade och/eller cyklade mer än 60 minuter per dag eller var mer fysiskt 
aktiva på arbetet hade lägre risk att utveckla grå starr, jämfört med de som var mindre 
fysiskt aktiva. Sambandet var ännu starkare för de som konsekvent hade en hög total fysisk 
aktivitet under en längre tidsperiod. Däremot var mycket stillasittande på fritiden associerat 
till ökad risk för grå starr. Jämfört med de två tidigare publicerade prospektiva studierna 
som undersökte fysisk aktivitet (främst träning) och risk för grå starr endast bland deltagare 
som redan tränade mycket, visar dessa resultat att fysisk aktivitet kan vara en skyddande 
faktor mot grå starr även i en generell population. 
   
Resultaten i denna avhandling visar att samspelet mellan olika antioxidanter kan skilja sig 
beroende på hälsostatus och att systemisk oxidativ stress kan vara kopplat till grå starr. I en 
generell population med relativt god nutritionsstatus verkar användandet av kosttillskott i 
form av multivitaminer inte ha någon större påverkan på risken för grå starr, däremot kan 
användande av enskilda vitaminer i höga doser vara associerat med ökad risk. Fysisk 
aktivitet kan vara en skyddande faktor mot grå starr, medan mycket stillasittande kan vara 
kopplat till ökad risk. Sammanfattningsvis tyder resultaten på att minskad systemisk 
oxidativ stress, t ex genom att äta en allsidig kost rik på antioxidanter istället för att 
använda kosttillskott, och att vara fysiskt aktiv regelbundet kan minska risken för grå starr. 
För framtida studier kan det vara värdefullt att undersöka oxidativ stress och antioxidanter i 
olika populationer, t ex bland högrisk grupper med lågt antioxidantintag, samt med hänsyn 
till hälsostatus.  
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  1 
1 INTRODUCTION 
Oxidative stress is a condition of disrupted balance between oxidants and antioxidants, 
towards excessive amounts of oxidants or insufficient antioxidant activity.
1 
It has been 
related to the aging process and a variety of diseases.
2-4
 Age-related cataract is a clouding 
of the lens that leads to disturbed vision and is one of the major causes of visual impairment 
worldwide.
5
 Oxidative stress is suggested to be involved in the etiology of cataract. Since 
the lens is under target of oxidation, there is a need of efficient antioxidant systems in the 
eyes to protect against oxidative damage. Some of the known risk factors for cataract 
include both non-modifiable (such as age and gender) and modifiable (lifestyle-related) 
factors.
5
 Since the only treatment for cataract today is through surgery (cataract extraction), 
it is of public health importance to find modifiable risk factors for cataract prevention. The 
aim of this thesis was to examine the association between oxidative stress, including 
biomarkers of antioxidants and systemic oxidative stress and inflammation, as well as 
modifiable diet and lifestyle factors related to oxidative stress, such as vitamin supplement 
use and physical activity, and the risk of age-related cataract among women and men in two 
large, population-based cohorts in Sweden. 
  
 2 
2 BACKGROUND 
2.1 OXIDATIVE STRESS 
Oxygen is a molecule essential for the existence of life, but it has also the property of 
becoming toxic through the generation of reactive oxygen species (ROS).
1
 Antioxidants 
protect cells and tissues from oxidative damage by scavenging free radicals. During normal 
physiological conditions there is a balance between levels of oxidants and antioxidants. 
However, if this balance is disrupted towards excessive amounts of oxidants or insufficient 
antioxidant activity, a condition known as oxidative stress arises (Figure 1).
1
 
 
         
        
Figure 1. Oxidants and antioxidants under normal conditions (balance) and during oxidative 
stress (disrupted balance due to insufficient antioxidant activity or excessive oxidants levels). 
 
Several biomarkers of oxidative stress have been used to assess oxidative stress in vivo, 
including biomarkers of lipid peroxidation such as thiobarbituric acid reactive substances and 
malondialdehyde, and different assays have been developed to measure the biomarkers.
6
 
However, it has been difficult to measure the “true” oxidative stress levels because of the 
reactivity of ROS. In the 1990’s, the isoprostanes were discovered by Morrow et al.7 and are 
today considered as one of the most reliable biomarkers for measuring oxidative stress in 
vivo. F2-isoprostanes, including the most abundant 8-iso-prostaglandin F2α (PGF2α), are 
formed during free radical-catalyzed peroxidation of arachidonic acid and can be measured in 
a variety of body fluids, such as blood and urine.
8
 Several methods have been developed and 
used to measure levels of F2-isoprostanes, including mass spectrophotometry, enzyme- and 
radioimmunoassays.
6,8,9
  
 
  3 
2.1.1 Oxidants 
Reactive species, including reactive oxygen and nitrogen species (ROS and RNS), are free 
radicals (i.e. molecules with unpaired electrons), and non-radicals, that are partly generated 
through cellular processes such as cell metabolism and signaling.
1
 Low levels of reactive 
species are vital for proper cell function and have an important role in cell signaling (e.g. 
regulating expression of antioxidant enzymes and other molecules), but excessive amounts 
can be harmful and lead to increased oxidative stress.
1
 ROS and RNS can start rapid chain 
reactions with for example long-chain polyunsaturated fatty acids leading to lipid 
peroxidation and oxidative damage of cells and tissues. Proteins and nucleic acids are also 
target for oxidation.
10
 Several endogenous and exogenous/environmental factors may 
influence or induce ROS production (Figure 2). 
 
 
 
Figure 2. Examples of endogenous and exogenous (environmental) factors influencing or 
inducing the generation of reactive oxygen species. 
 
The superoxide anion (O2
•-
) is a common ROS and free radical produced by many cells 
during for example cell metabolism. Superoxide can react and form hydrogen peroxide 
(H2O2), a non-radical, which in turn may lead to generation of the very reactive hydroxyl 
radical (OH
•
) that can cause oxidative damage (Figure 3). Superoxide may also react with 
nitric oxide (NO
•
) to form peroxynitrite (ONOO
-
, example of RNS). Nitric oxide has an 
important role in cell signaling and in the central nervous system by regulating blood pressure 
as a vasodilator.
11
 
 4 
 
Figure 3. A schematic overview of common reactive oxygen species generated from oxygen 
(O2), including superoxide (O2
•-
), hydrogen peroxide (H2O2) and hydroxyl radicals (OH
•
), that 
may lead to oxidative damage of lipids, proteins and DNA. The defense by endogenous 
antioxidants (enzymes), including superoxide dismutase, glutathione peroxidase and catalase, 
is also shown.  
 
2.1.2 Antioxidants 
Antioxidants have been defined as “any substance that delays, prevents or removes oxidative 
damage to a target molecule”.1 Antioxidants participate in redox-reactions and reduce the 
formation of reactive species through donation of electron(s). The oxidized form of the 
antioxidant may in turn be reduced by other antioxidant enzymes/systems back into its 
reduced (active) state. Different types of antioxidants include exogenous (dietary) and 
endogenous antioxidants (produced in the body) and they may co-operate in a complex 
network and have synergistic effects against oxidative stress.
12
 Antioxidants may also be 
divided into enzymatic and non-enzymatic ones. The levels and activity of antioxidants may 
be influenced by several factors, such as genetic factors, the redox-status of a cell, diet and 
health condition/diseases (e.g. inflammation).
1,13
 An important mechanism of the cellular 
defense against oxidative stress is the regulation of antioxidant expression by different 
transcription factors related to oxidative stress and inflammation, such as nuclear factor κβ, 
retinoic acid (a metabolite of vitamin A) and nuclear factor E2-related factor 2 (Nrf2).
14,15
 
The transcription factors can activate different signaling pathways by binding to responsive 
elements on genes, for example Nrf2 binds to the antioxidant response element, which is an 
enhancer sequence found on genes encoding antioxidant/detoxifying enzymes (sensitive to 
changes in redox status).
16
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2.1.2.1 Exogenous antioxidants 
Exogenous antioxidants are provided from dietary sources, mainly from fruit and vegetables, 
which are rich in vitamins and antioxidants.
10
 Vitamins are a heterogenic group of nutrients 
that are essential for the body. Observational epidemiological studies have shown that high 
fruit and vegetable intake and blood concentrations of different vitamins may be protective 
against many diseases, including several cancers, cardiovascular disease (CVD) and 
cataract.
17-27
 An overview of the common dietary antioxidants carotenoids, vitamin C and 
vitamin E and their dietary sources, physiological functions and antioxidant properties are 
presented in Table 1. 
 
Table 1. Summary of dietary sources and antioxidant/physiological functions of antioxidants  
Antioxidants Dietary sources Antioxidant properties Other physiological functions  
Carotenoids Fruit and vegetables 
(especially those with 
yellow/red color and 
green leafy vegetables) 
Lutein/zeaxanthin in the eye 
(absorbs blue light) 
Prevents lipid peroxidation 
 
Pro-vitamin A
a
:  
Vision  
Growth and development 
Immune system 
 
Vitamin C Fruit and vegetables 
(especially citrus fruits, 
broccoli and pepper) 
Scavenges reactive species 
Regenerates other antioxidants 
 
Collagen formation  
Cofactor for enzymes 
Immune system 
Vitamin E Vegetable oils, cereals, 
nuts and legumes 
Prevents lipid peroxidation 
Protects cell membranes 
against oxidative damage 
Regenerates other antioxidants 
Cell signaling and gene 
expression 
Neurological function 
 
a 
The carotenoids α-carotene, β-carotene and β-cryptoxanthin are pro-vitamin A. 
 
Carotenoids are lipophilic compounds found as natural pigments in plants, fungi and algae. 
The bioavailability of carotenoids may be influenced by cooking method, for example 
heating tomatoes in oil improves the bioavailability of lycopene.
28
 The antioxidant potential 
of the carotenoids includes scavenging radicals generated from lipid peroxidation.
23
 In 
humans, major carotenoids found in plasma are lycopene, lutein/zeaxanthin, α-carotene, β-
carotene and β-cryptoxanthin.20,23 Among the carotenoids, α-carotene, β-carotene and β-
cryptoxanthin can be converted into vitamin A in the body and are called pro-vitamin A. 
Carotenoids are considered as reliable biomarkers for estimating fruit and vegetable intake.
29
  
 
Vitamin C (ascorbic acid/ascorbate and its derivatives) is a hydrophilic nutrient found in most 
fruit and vegetables. The content of vitamin C may be reduced during long-term storage or 
cooking.
10
 Vitamin C has antioxidant properties through protection against reactive species 
and the regeneration of other antioxidants, including vitamin E.
1
 Dehydroascorbic acid is the 
oxidized form of vitamin C that can be reduced back to ascorbic acid (reduced form) by other 
antioxidants, such as glutathione. However, at high concentrations and especially in the 
presence of metal ions, it can also be a pro-oxidant (inducing radicals).
30,31
  
 6 
Vitamin E consists of a group of 8 lipophilic compounds with similar structures, including 
tocopherols and tocotrienols. Dietary sources rich in vitamin E are vegetable oils, cereals and 
nuts. Vitamin E has antioxidant properties; it scavenges radicals and protects other oxidizable 
compounds, such as polyunsaturated fatty acids, vitamin A and D. As a result, a large 
proportion of the vitamin may be lost during long-term storage or cooking.
10
 Vitamin E at 
high concentrations may also have pro-oxidative properties.
32,33
  
 
In addition to the previously described antioxidant vitamins, B vitamins are a group of 
hydrophilic compounds found in a variety of foods, especially in cereals and meat, and have 
an important role in cell metabolism.
10
 Some experimental studies indicate that B vitamins 
may have antioxidant properties
34-37
 by for example inhibiting formation of advanced 
glycation end products
38
 and protein oxidation in lens cells.
39
 B vitamins at high 
concentrations have also shown toxic and pro-oxidative properties.
40,41
  
 
2.1.2.2 Endogenous antioxidants 
Antioxidants that are produced endogenously include different antioxidant enzymes and other 
non-enzymatic molecules such as glutathione.
1
 One important group of enzymatic 
antioxidants is the superoxide dismutase (SOD) family, with the main function to scavenge 
superoxide anions (Figure 3). Three types of SODs have been identified in humans: cytosolic 
Cu/Zn SOD (SOD1), mitochondrial Mn-SOD (SOD2) and extracellular Cu/Zn SOD (SOD3; 
EC-SOD).
42
 The EC-SOD was discovered in 1982 by Marklund et al.
43
 and is a hydrophobic 
glycoprotein found in extracellular fluids. Different molecules may regulate EC-SOD gene 
expression, such as pro-inflammatory cytokines and other antioxidants.
44,45
 It has also been 
suggested that a mild pro-oxidative state (through intake of natural pro-oxidants in foods) in 
the gastrointestinal tract may lead to up-regulation of endogenous antioxidants.
46
 Studies 
have shown altered levels and activity of EC-SOD in association with chronic diseases, such 
as diabetes and CVD.
47-49
 Carotenoids, being an important group of exogenous (dietary) 
antioxidants, are suggested to have antioxidant potential and may be involved in the 
regulation of gene expression of endogenous/enzymatic antioxidants.
23,50
 Examples of other 
antioxidant enzymes are glutathione peroxidase and catalase, which catalyzes the reduction of 
hydrogen peroxide in different reactions (Figure 3).  
 
Glutathione is an important non-enzymatic antioxidant produced endogenously from different 
amino acids that can prevent oxidative damage by reducing disulfide bonds. It exists in both a 
reduced (glutathione) and oxidized (glutathione disulfide) state. The enzyme glutathione 
reductase converts the oxidized form (glutathione disulfide) back into its reduced state.
11
 
Glutathione is also important for the function of other antioxidants, such as 
glutaredoxins/thioltransferases.
51
  
 
  7 
2.2 AGE-RELATED CATARACT 
Age-related cataract is defined as a clouding/opacification of the lens, which leads to 
impairment of the vision and is one of the leading causes of low vision and blindness in the 
world.
52
 The lens is normally transparent and located in a collagen capsule behind the pupil in 
the eye. Incoming light passes through the lens and is refracted to the retina. Through 
accommodation, the shape of the lens is adjusted by contraction and relaxation of ciliary 
muscles to allow the eye to see sharply and focus at different distances (Figure 4). 
 
 
 
Figure 4. In the eye an image is formed at the retina from light refracted in the lens. 
 
The cell types found in the lens are the epithelial cells (found on the anterior side of the lens) 
and the fiber cells. The lens is continuously growing as the epithelial cells divide into new 
fiber cells and pushing already existing fiber cells into the center of the lens, which becomes 
denser, thicker and less elastic with increasing age. In order to get optimal visual acuity it is 
important that the lens is clear. The transparency of the lens is due to densely packed lens 
fiber cells with a minimum of extracellular space and the absence of cell organelles in the 
fiber cells. Oxidative damage to lens proteins (mostly crystallins) contribute to degradation of 
the normal architecture and cloudiness of the lens. Some of the symptoms of cataract include 
cloudy/blurry vision, glare, decreased night vision, double vision and need for brighter light 
when reading. There are three subtypes of cataract depending on its location in the lens: 
nuclear, cortical and posterior subcapsular cataracts. The symptoms may vary between the 
subtypes. Nuclear cataract has been shown to be the predominant subtype in many 
populations and includes opacification of the nucleus of the lens, that is when lens proteins of 
the older fiber cells deteriorate/oxidize and the lens become denser and less elastic.
53,54
 The 
development of nuclear cataract may progress slowly and leads to impairment of mostly 
distant vision. Cortical cataract refers to opacities in the lens cortex (the peripheral edge of 
the lens) and occurs when the younger lens fiber cells deteriorate and change in water 
content, leading to blurred vision and glare. In posterior subcapsular cataract, the 
opacification is located on the back surface of the lens, beneath the lens capsule, which can 
lead to difficulties when reading and glare. Risk groups for this subtype of cataract include 
 8 
people who have diabetes or are using corticosteroids.
5
 Posterior subcapsular cataract may 
develop relatively rapidly and give rise to notable symptoms within months.   
 
The etiology of cataract is suggested to be multifactorial. Risk factors for cataract include 
both non-modifiable factors such as age, gender and genetics, as well as modifiable factors 
such as smoking, alcohol, ultraviolet radiation, overweight, hypertension, diabetes and use of 
corticosteroids.
5,55-62 
 
2.2.1 Prevalence and incidence 
According to the World Health Organization’s (WHO) latest assessment, approximately 51% 
of the world blindness may be due to cataract, representing about 20 million people (2010).
52
 
The access to cataract extraction (surgery) differs between countries and in many countries 
the availability of cataract extraction is limited.
63
 As people live longer, the incidence of 
cataract is expected to increase worldwide, with an estimated doubling by the year 2020.
63
 
 
2.2.2 Cataract extraction  
Cataract extraction (surgery) is the only treatment available for cataract today. It is performed 
on an outpatient basis and is a common (some variation depending on country) and generally 
safe surgery. Briefly, the cataractous/cloudy lens is removed and replaced by, in most cases, 
an artificial lens. In Sweden, cataract extraction is the most commonly performed surgery 
with approximately 110,000 operations/year (Figure 5).
64
  
 
 
Figure 5. Numbers of cataract extractions in Sweden between 1980 and 2013 (data from the 
Swedish National Cataract Register).
64
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2.3 OXIDATIVE STRESS AND AGE-RELATED CATARACT 
2.3.1 Oxidants and antioxidants in the lens 
Oxidative damage of the lens is suggested to be involved in the etiology of age-related 
cataract, and lipid oxidation and glycation of proteins in the lens have been associated with 
cataract development.
30,51,65
 Several biomarkers of oxidative stress have been shown to be 
higher in the cataract lens as compared to non-cataract lens (in both humans
65,66
 and 
animals
30,67
).  
 
Antioxidants in the eye protect the lens from oxidative stress.
51
 Several exogenous/dietary 
antioxidants have been detected in different parts of the human lens, which include the 
hydrophilic ascorbate (vitamin C)
68
 and the fat-soluble lutein/zeaxanthin (the only 
carotenoids), vitamin E and retinol.
69
 The concentrations of the fat-soluble antioxidants in the 
lens have been shown to be approximately 2-3-fold higher in the younger and more 
metabolically active epithelial/cortical layers of the lens as compared to the older nuclear 
layers of the lens.
69
 The lens contains relatively large amounts of ascorbate, which scavenges 
reactive oxygen species such as superoxide.
68
 However, ascorbic acid may also have pro-
oxidative properties and contribute to aging of the lens crystallins (protein oxidation by the 
Maillard reaction), especially in the presence of high metal concentrations.
30,31
 Vitamin E (α-
tocopherol) supplementation has been shown to protect, in a dose-response manner, against 
ultraviolet radiation induced cataract.
70
 Moreover, high concentrations of lutein/zeaxanthin in 
the lens have been shown to decrease oxidative stress.
71
 
 
 
 
The human lens also includes endogenous antioxidants, such as SOD and glutathione.
51
 The 
levels of SOD in different ocular tissues varies and SOD activity was found to be highest in 
the retina and lowest in the lens (15-fold less compared to the average human tissue) and the 
majority was cytosolic CuZn-SOD.
72
 The enzymes seem to have an important role in 
protecting the eye and the lens against oxidative stress. Knock-out mice lacking cytosolic 
CuZn-SOD have been shown to develop cataract faster than control mice and they also had 
higher levels of intracellular superoxide-derived oxidative stress.
73
 Human cataract lens has 
been shown to have lower CuZn-SOD activity, as compared to non-cataract lens.
74
  
 
Glutathione, another important antioxidant in the lens, may co-operate with vitamin C to 
scavenge ROS and is found at high levels in the lens.
51
 There are also two repair systems in 
the lens, the glutathione-dependent glutaredoxin/thioltransferase system and the NADPH-
dependent thioredoxin system that help to maintain redox homeostasis by reducing oxidized 
proteins and enzymes.
51,67
 Experimental studies have shown for example that knock-out mice 
lacking glutaredoxin 2 developed age-related cataract faster than age-matched controls.
66
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2.3.2 Systemic oxidative stress and inflammation  
Previous cross-sectional
75
 and case-control
76-78
 studies have observed higher concentrations 
of systemic oxidative stress biomarkers, such as malondialdehyde and hydroxyoctadeca-
dienoic acid, in patients with cataract. However, few studies (one cross-sectional
75
 and one 
case-control
79
 study) have examined the association between 8-iso-PGF2α, which is 
considered as one of the most reliable biomarkers of oxidative stress in vivo,
7
 and risk of 
cataract. Only the case-control study observed a statistically significant positive association 
between plasma 8-iso-PGF2α concentrations and cataract risk.  
 
High levels of chronic or acute inflammation may induce oxidative stress. Inflammation has 
also been suggested to increase the risk of cataract. However, few studies have investigated 
the association of systemic inflammation with risk of cataract and reported inconsistent 
results. Two studies have observed a positive association for the inflammatory biomarkers 
serum C-reactive protein
80
 and interleukin-6
81
 with risk of cataract, but others found no 
association between serum C-reactive protein and cataract risk.
81,82
  
 
2.3.3 Antioxidants in diet and supplements 
Observational epidemiological studies have shown an inverse association between diets rich 
in antioxidants such as high fruit and vegetable intake and high intakes of β-carotene, 
lutein/zeaxanthin, vitamin C and vitamin E, and risk of cataract, that has been attributed to the 
ability of antioxidants to prevent oxidation processes in the lens and systemically.
83-87
 A 
meta-analysis of observational studies reported an inverse association between concentrations 
of some blood antioxidants and vitamins, including α-carotene, lutein/zeaxanthin and vitamin 
E, and risk of cataract, especially in populations with micronutrient deficiencies at baseline.
88
 
Moreover, high total antioxidant capacity (a measure that takes into account the levels and 
synergistic effects of many antioxidants in the diet) has also been associated with decreased 
risk of cataract extractions in a population-based prospective cohort study of women.
89
 
 
Although several studies have observed an inverse association between diets rich in 
antioxidants and cataract, observational studies examining the use of dietary supplements 
containing an individual or a combination of antioxidants/vitamins have shown inconsistent 
results (previously reviewed by Mares
90,91
 and Seddon
92
). A summary of the observational 
studies examining dietary supplement use and risk of cataract is shown in Table 2.
84,87,93-102
 
Randomized controlled trials (RCTs) investigating the effect of high-dose supplements, 
including vitamin C, vitamin E and β-carotene, either individually or in a combination, with 
risk of cataract, have mostly shown no effect, although a small deceleration in cataract 
progression was reported in one trial
103
 (previously reviewed by Mares,
90,91
 Mathew et al.,
104
 
and Chew
105
). The RCTs investigating the effect of dietary supplement use for cataract 
prevention are summarized in Table 3.
103,106-116
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In general, several large RCTs investigating the effect of single, high-dose vitamin/ 
antioxidant supplements for prevention of chronic diseases have failed to show any protective 
effect.
117-121 
Indeed, some RCTs have even reported harmful effects of high-dose antioxidant 
supplements for risk of CVD,
122
 some types of cancers
123-125 
and mortality.
126
  
 
For the use of multivitamins (containing doses close to recommended daily intake, RDI), on 
the other hand, three RCTs have reported a modestly decreased risk of total and nuclear 
cataracts.
114-116
 One of the trials (the Linxian Cataract Studies) was based on a study 
population with micronutrient deficiencies at baseline,
114
 while the other two trials were 
conducted among generally well-nourished study populations (the Italian-American Clinical 
Trial of Nutritional Supplements and Age-Related Cataract and Physicians’ Health Study 
II).
115,116
  
 
2.3.4 Physical activity 
Physical activity is associated with several health benefits, such as reduced oxidative stress 
and inflammation levels, improved lipid profiles and insulin sensitivity.
127-129
 It is a protective 
factor for many chronic diseases, including diabetes and coronary heart disease.
127,130
 On the 
other hand, physical inactivity has been associated with higher levels of oxidative 
stress
129,131,132
 and increased risk of many diseases.
130
 Only two previous prospective cohort 
studies have observed, in physically active populations, that higher moderate (walking)
133
 and 
vigorous (running)
133,134
 physical activity levels were associated with decreased risk of 
cataract in men
133,134
 and women.
133
 One case-control study conducted at a hospital setting 
observed that lower physical activity levels were associated with increased risk of cataract.
135
 
However, little is known about the association between total and specific types of physical 
activity and risk of age-related cataract in a general population.  
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3 AIMS 
The overall aim of this thesis was to examine the role of oxidative stress biomarkers and 
oxidative stress-related diet and lifestyle factors with the risk of age-related cataract.  
 
 
The specific aims were: 
 
 To study the association between exogenous/dietary and endogenous antioxidants in 
women and whether this association differs in healthy women vs. those with a 
history of chronic diseases.  
 
 To examine the association between systemic oxidative stress and inflammation, as 
measured by urinary biomarkers, and risk of cataract incidence in women. 
 
 To prospectively assess the association between use of high-dose vitamin C and 
vitamin E supplements, as well as low-dose multivitamins, and risk of cataract 
incidence in men. 
 
 To prospectively assess the association between high-dose B vitamins supplement 
use and risk of age-related cataract incidence in women and men.  
 
 To prospectively assess the associations of total and specific types of physical 
activity, as well as leisure time inactivity, with risk of cataract incidence in women 
and men.  
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4 PARTICIPANTS AND METHODS 
4.1 STUDY POPULATIONS 
The papers in this thesis are based on two population-based studies:  
1) The Swedish Mammography Cohort (SMC) 
2) The Cohort of Swedish Men (COSM) 
 
4.1.1 Swedish Mammography Cohort 
The SMC was established in 1987-1990. All women born (n=90,303) between 1914 and 
1948 and living in Uppsala and Västmanland Counties in central Sweden received an 
invitation to a mammography screening program and, together with the invitation, a mailed 
questionnaire including questions regarding diet (67-item food frequency questionnaire, FFQ) 
and lifestyle factors. Approximately 74% of the women responded. The aim of the SMC was 
to study the association between lifestyle factors and major chronic diseases, including age-
related cataract. To update exposure information, a second extended follow-up questionnaire 
(including a 96-item FFQ) was sent in late fall 1997 to the women, aged 48-83 years, who 
were alive and still living in the study area. Approximately 70% of the women responded.  
 
The study populations in Papers IV and V include women from the SMC. The baseline 
exposure assessment was based on data from the 1997 questionnaire, since it contained more 
information on known and potential confounders than the previous 1987 questionnaire. 
Briefly, for each study, participants were excluded if they had missing or erroneous personal 
identity number, turned in a blank questionnaire or died before January 1, 1998. To avoid 
influence of potential changes in diet and lifestyle factors, participants were also excluded if 
they had a previous cancer diagnosis other than nonmelanoma skin cancer, or a history of 
cardiovascular disease and/or diabetes. Moreover, those with cataract diagnosis or cataract 
extraction before the baseline 1998 and those with missing information on any of the 
exposure variables (e.g. dietary supplement use and physical activity levels) were also 
excluded. A more detailed description of the exclusions for each study is presented in the 
flow-chart (Figure 6) and the published papers.  
 
4.1.1.1 The Swedish Mammography Cohort – Clinical (SMC–C)  
The clinical sub-cohort of the SMC, the SMC–C, was established between 2003 and 2009, a 
total of 8311 women (<85 years) living in Uppsala County were invited to complete a third 
questionnaire regarding diet and lifestyle factors (similar to the 1997 questionnaire) and to 
undergo a health examination (including measurements of weight, height, waist, hip and 
blood pressure, as well as a dual energy X-ray absorptiometry scan). Approximately 65% of 
the women completed the questionnaire and 61% participated in the health examination. 
Fasting blood and urine samples and other biologic materials (e.g. adipose tissue) were 
collected at the health examination. 
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Papers I and II (including biomarkers) are based on women from the SMC–C and recruited 
between 2003 and 2005. For Paper I, 157 women aged 55-74 years that had donated blood 
samples and answered the third questionnaire were randomly selected from the SMC–C and 
included in the study. Two women were excluded, because of fruit and vegetable intake 
outside the range of 133-1572 g/day (±2.5 standard deviation on a log scale). In Paper II, a 
total of 258 cases and 258 controls were included. Cases were defined as women with 
incident age-related cataract (diagnosis and/or cataract extraction after the date of urine 
sample collection and through December 2009). For each case, one control without cataract 
was randomly selected and matched for age (same year of birth) and date of urine sample 
collection (within 1-5 months). Excluded were women with a history of cataract diagnosis, 
cataract extraction, or cancer at the time of health examination and collection of urine 
samples. 
  
4.1.2 Cohort of Swedish Men 
The COSM was established in late fall 1997 with the aim to study lifestyle factors and major 
chronic diseases, including age-related cataract. All men (n=100,303), aged 45-79, living in 
central Sweden (Örebro and Västmanlands Counties) received a questionnaire regarding diet 
and lifestyle factors (same questionnaire as for the SMC, except for gender specific 
questions). Approximately 49% of the men completed the questionnaire. 
 
The study populations in Papers III-V included participants from the COSM. Paper III was 
based on COSM participants only and Papers IV and V were based on participants from 
both the COSM and the SMC. The exposure assessment was based on data from the 1997 
questionnaire (study baseline). The same exclusion criteria (as for the SMC) were applied in 
the studies and participants were excluded if they had missing or erroneous personal identity 
number, turned in a blank questionnaire, died before January 1, 1998, had a previous cancer 
diagnosis other than nonmelanoma skin cancer, or a history of cardiovascular disease and/or 
diabetes. Moreover, men with cataract diagnosis or cataract extraction before baseline and 
those with missing information on any of the exposure variables were also excluded. The 
flow-chart (Figure 6) shows a more detailed description of the exclusions made in each study 
and this information can also be found in the published papers.  
 
4.2 METHODS 
4.2.1 Study designs 
Observational epidemiological studies examine the distribution, determinants (protective and 
risk factors) and/or occurrence of a disease, by making observations in a study population. 
Different types of observational studies include cross-sectional, case-control and cohort 
studies. The study design of each paper included in this thesis is presented in Figure 6. 
  19 
 
 
 
 
Figure 6. Flow-chart of the Swedish Mammography Cohort and the Cohort of Swedish Men, 
including source and study populations, exclusions and study designs for Papers I-V. 
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Paper I is a cross-sectional study, which is a type of study where the exposure and outcome 
of interest are collected at the same time, representing a “snapshot” of the population status at 
a single/specific point in time. Paper II is a nested case-control study, which is a case-control 
study conducted within (“nested”) a cohort, the SMC–C, and includes incident cataract cases 
and controls without cataract matched on age and date of urine sample collection. Papers III-
V are prospective cohort studies, which are based on participants from the COSM and/or 
SMC that are free from cataract at baseline (start of follow-up). The participants are followed 
over a period of time and cataract incidence is compared between exposed and unexposed 
individuals (i.e. dietary supplement users vs. non-users or high vs. low physical activity 
levels). Information on diet and lifestyle habits, as well as health status is collected during the 
study period through a self-administered questionnaire and linkage to registers.  
 
4.2.2 Assessment of exposures and covariates 
4.2.2.1 Biomarkers of antioxidants, oxidative stress and inflammation (Papers I and II) 
Fasting blood and urine samples (one of each for all the study participants) were collected at 
the health examination. The blood samples were collected in evacuated tubes (containing 
EDTA) and immediately centrifuged for 10 min, at 4 °C, in a dark room. Plasma was 
separated from the blood samples and stored at -80 °C until analysis. The urine samples were 
also stored at -80 °C until analysis. 
 
Plasma EC-SOD activity was analyzed with a commercial kit (Cayman Chemical Company, 
Ann Arbor, MI). In this assay, based on the xanthine oxidase system, superoxide was 
generated by adding diluted xanthine oxidase and the levels of superoxide (detected using a 
tetrazolium salt) were measured spectrophotometrically at 450 nm. The activity of EC-SOD 
was calculated from an equation based on the linear regression from the standard curve and 
defined as units (U). One unit was defined as the amount of enzyme needed to exhibit 50% 
dismutation of the superoxide radical. All the standards and plasma samples were analyzed in 
duplicates. The inter- and intra-assay coefficients of variations were 8.6% and 7.1%, 
respectively.  
 
Plasma concentrations of lycopene, lutein/zeaxanthin, α-carotene, β-carotene and β-
cryptoxanthin were measured using a previously described method.
136
 Briefly, plasma 
carotenoids were separated and quantified using high-performance liquid chromatography 
and determined spectrophotometrically at 470 nm. The results obtained were compared with 
standard curves from lycopene, lutein/zeaxanthin, α-carotene, β-carotene and β-cryptoxanthin 
standards. Analysis of serum cholesterol was performed at Uppsala University Hospital. 
Concentrations of serum total cholesterol were measured with Konelab 20 analyzer (Thermo 
Electron Oy, Vantaa, Finland) and cholesterol reagent was purchased from Thermo Electron 
Corporation (ref. no 981813, Vantaa, Finland).  
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Analysis of urinary 8-iso-PGF2α, 15-keto-dihydro-PGF2α and creatinine concentrations were 
performed at Uppsala University, using radioimmunoassays developed and previously 
described by Basu.
8,137
 The intra-assay coefficient of variation was 14.5% at low and 12.2% 
at high concentrations for 8-iso-PGF2α. The detection limit of the assay was 23 pmol/L. For 
the 15-keto-dihydro-PGF2α assay, the intra-assay coefficient of variation was 12.2-14.0% and 
the limit of detection was 45 pmol/L. Both urinary 8-iso-PGF2α and 15-keto-dihydro-PGF2α 
was corrected for urinary creatinine levels. Creatinine levels were measured by a colorimetric 
method described elsewhere.
138
  
 
4.2.2.2 Diet and dietary supplements (Papers I, III and IV) 
Fruit and vegetable intake was estimated from a 96-item FFQ completed by the participants 
at study baseline. They have answered questions on how often, on average, during the past 
year they had consumed different food items. There were eight different consumption 
frequency categories to choose from, ranging from never to three times or more daily, for 
each food item. The average consumption (g/day) of each food item was calculated by 
multiplying the frequency of consumption by age-specific portion sizes. The variable total 
fruit intake was created by adding the fruit items asked for in the FFQ, which included 
oranges/citrus fruits, orange/grapefruit juice, apples/pears, bananas, berries, fruit soups and 
other fruits. For total vegetable intake, the vegetable items asked for in the FFQ were added 
and included carrots, beetroots, lettuce/iceberg lettuce, cabbage, brussels sprouts, cauliflower, 
broccoli, tomatoes/tomato juice, pepper, spinach, green peas, onions, garlic, mixed 
vegetables, beans/lentils and soya products.  
 
Intakes of single nutrients from the diet, such as vitamin C, vitamin E and B vitamins, were 
assessed based on the estimated average consumption of different food items from the FFQ. 
Nutrient intakes were estimated by multiplying the frequency of consumption of food items 
by age-specific portion sizes and the nutrient composition obtained from the Swedish 
National Food Agency.
139
 The nutrient intakes were adjusted for energy intake using the 
residual method.
140
 The 1997 FFQ has been validated among 248 men (aged 40-74 years) 
from the COSM, who received the same FFQ as the women in the SMC 1997. The FFQ had 
relatively good validity compared to 14 interviews (24-h recalls) for micronutrient intake, 
such as vitamin C, vitamin E and vitamin B6 (all correlation coefficients ≈0.6).141 
 
Information on dietary supplement use was obtained from the FFQ completed by the 
participants at study baseline, which included a general question “Do you use vitamin, 
mineral, or other supplements?” and three pre-specified responses (no, regular use and 
occasional use). Followed by this question were more specific questions on dietary 
supplement use including pre-specified types of supplements (including multivitamins, 
vitamin C, vitamin E and B vitamins) and open answers about frequency and duration of use. 
Supplement users were defined as participants who reported regular or occasional supplement 
use. Duration (number of years) of dietary supplement use, including use of multivitamins 
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and single vitamins, such as vitamin C, vitamin E and vitamin B6, was inquired by open-
ended questions. Long-term and short-term supplement users were defined as those who 
reported use ≥10 and <10 years before baseline, respectively. Supplement doses were 
estimated through information based on the commonly used supplements on the Swedish 
market during the study period.
142
 The doses for single vitamins (vitamin C, vitamin E and B 
vitamins) were estimated to be approximately 10 times higher than the RDI and were defined 
as high-dose supplements. Multivitamins containing vitamin doses close to the RDI were 
defined as low-dose supplements. A validity study of the self-reported supplement use data 
for men in the COSM has shown relatively high validity (the sensitivity for the FFQ 
regarding use of any dietary supplements was 78% and the specificity was 93%).
143
 
 
4.2.2.3 Assessment of physical activity (Paper V) 
Levels of physical activity were assessed by using a self-administered questionnaire with 6 
questions about physical activity and inactivity habits during the previous year (study 
baseline) and at age 30 years. The specific types of physical activities and the predefined 
alternatives for time spent on each activity (5-6 alternatives) included: walking/bicycling 
(hardly ever to more than 1.5 h daily), leisure time exercise (less than 1 h to more than 5 h 
weekly), work/occupational activity (mostly sitting to heavy manual labor), home/housework 
(less than 1 h to more than 8 h daily) and inactive leisure time (e.g. sitting/reading/watching 
TV; less than 1 h to more than 6 h daily). In addition, there was an open-ended question on 
duration of sleep and time spent sitting/laying down daily. Activity levels of the specific 
types of activities were calculated by multiplying the intensity (defined as metabolic 
equivalents, MET, kcal/kg/h) by the self-reported duration (in hours) of the activities.
144
 Total 
physical activity (24 h) at baseline and at age 30 years were estimated by adding all specific 
activity types together. The self-reported physical activity data has been validated against 7-
day activity records in women and in men from the SMC and the COSM and shown to 
estimate total physical activity satisfactory (Spearman’s rank correlation: 0.6).145,146 
 
4.2.2.4 Assessment of covariates 
The self-administered questionnaire completed at baseline also included information on 
demographic, medical, lifestyle-related factors and other potential confounders, which were 
included as covariates in the multivariable-adjusted models in the papers. The following 
covariates were included (with some variation depending on the study, a more detailed 
description is presented in the statistical analysis section and in each paper): age, educational 
level, smoking status, alcohol intake, body mass index (BMI), abdominal obesity (defined as 
waist circumference ≥80 cm for women and ≥94 cm for men), self-reported health 
(information only available for men), history of CVD, diabetes or hypertension, and use of 
corticosteroids.  
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History of CVD was obtained from the National Inpatient and Outpatient Registers at the 
National Board of Health and Welfare. Diabetes history was obtained through the National 
Outpatient Register, National Diabetes Register and self-reports. History of hypertension was 
identified through linkage to the National Inpatient and Outpatient Registers and through self-
reported data from the questionnaire. Information on cancer diagnosis was obtained through 
linkage to the Swedish National Cancer Register.  
 
4.2.3 Case ascertainment and follow-up 
Incident age-related cataract cases, defined as participants with cataract diagnosis and/or 
cataract extraction after baseline during follow-up (Papers II-V), were identified through 
linkage to the National Outpatient and Inpatient Registers at the National Board of Health and 
Welfare (International Classification of Diseases (ICD)-10, code H25 and operation codes 
CJC, CJD, CJE, CJG). To complement the preceding data and for increased completeness, 
the cohorts were also matched against local cataract extraction registers from both public and 
private clinics (Papers II-V) and with the Swedish National Cataract Register (Papers IV 
and V), which has a coverage of approximately 97% of all cataract extractions in 
Sweden.
64,147
 Cataracts that were considered to be congenital or secondary to ocular trauma, 
intraocular inflammation, or previous intraocular surgery were excluded (ICD-10, code H26). 
According to data from the Swedish National Cataract Register, the median pre-operative 
best corrected visual acuity in the operated eye with cataract was 20/50 Snellen Equivalents 
(corresponding to reading difficulties) and the median pre-operative visual acuity in the non-
operated eye was 20/30 Snellen Equivalents for men and women during the study period.
64,147
 
 
In Paper II, incident cataract cases (n=258) were defined as women with cataract diagnosis 
and/or cataract extraction after the date of urine sample collection and through December 
2009. A control (woman without cataract diagnosis and/or cataract extraction during the 
follow-up time) was randomly selected for each case and matched for age (same year of 
birth) and date of urine sample collection (91.1% within 1 month and 8.9% within 2-5 
months). In the prospective cohort studies (Papers III-V), the participants were followed 
from baseline (January 1, 1998), until the date of cataract diagnosis, cataract extraction, death 
or the end of follow-up, whichever occurred first. In Paper III, a total of 2963 cataract cases 
were identified during the follow-up period between January 1, 1998, and December 31, 
2006. In Papers IV and V, a total of 5761 and 11,580 cataract cases were identified, 
respectively, during follow-up from January 1, 1998 to December 31, 2011. Date of death 
was identified through linkage to the Swedish Death Register. 
 
The studies included in this thesis were approved by the Regional Ethical Board at 
Karolinska Institutet (Stockholm, Sweden) and informed consent was obtained from the 
participants. 
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4.2.4 Statistical analysis 
The statistical analyses were performed with SAS software versions 9.2 and 9.3 (SAS Inc., 
Cary, NC) for analysis of linear regression, logistic regression and Cox proportional hazards 
models. Stata software versions 11 and 12 (StataCorp, College Station, TX) were used for 
Laplace regression, restricted cubic spline models and correction of risk estimates taking into 
account sensitivity and specificity of self-reported use of dietary supplements. All P values 
shown are 2-sided and P values <0.05 were considered as statistically significant.  
 
4.2.4.1 Cross-sectional study (Paper I) 
In Paper I, characteristic differences among the women were analyzed with analysis of 
variance. The distribution of plasma carotenoids, fruit and vegetable intake and plasma EC-
SOD activity was tested using residual and goodness-of-fit analyses. Pearson correlation 
coefficients were calculated to assess the association between plasma carotenoids/fruit and 
vegetable intake and EC-SOD activity. Partial Pearson correlation coefficients were also 
calculated to control for the potential effects of age, BMI, smoking, education, supplement 
use and serum total cholesterol concentrations on the observed associations. The mean EC-
SOD activity for each quartile of plasma carotenoids and fruit and vegetable intake in healthy 
and non-healthy women, respectively, was determined using a multivariable regression model 
adjusted for the same covariates as in the partial Pearson correlation model. The differences 
in mean EC-SOD activity across the quartiles and between healthy and non-healthy women 
were tested using Student’s t test.  
 
4.2.4.2 Nested case-control study (Paper II) 
In Paper II, the differences in characteristics between cases and controls were tested using 
analysis of variance. Spearman correlation coefficients were calculated to assess the 
correlation between 8-iso-PGF2α and 15-keto-dihydro-PGF2α levels and were adjusted for 
BMI, smoking, education, use of corticosteroids, history of diabetes and history of CVD. 
Conditional logistic regression was performed given the matched group to calculate odds 
ratios (ORs) and 95% confidence intervals (CIs) for age-related cataract by 8-iso-PGF2α and 
15-keto-dihydro-PGF2α levels (median and quartiles). The multivariable model was adjusted 
for the same covariates as described above and additionally for potential dietary confounders, 
including alcohol intake, fruit and vegetable consumption and antioxidant supplement use 
(vitamin C, E, beta-carotene, zinc and multivitamins). To test for trends across the quartiles of 
8-iso-PGF2α and 15-keto-dihydro-PGF2α, a single numeric variable was created using the 
median value of each quartile.
 
In a sensitivity analysis, the conditional logistic regression was 
restricted to only include women without a history of diabetes or CVD and not using 
corticosteroids at baseline, because these factors have been associated with both increased 
oxidative stress and risk of cataract.
5
 The dose-response relationship between 8-iso-PGF2α as 
a continuous variable and risk of cataract was flexibly modeled using restricted cubic splines 
with three knots of the distribution (at 0.27, 0.42, and 0.75 nmol/mmol creatinine).  
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4.2.4.3 Cohort studies (Papers III-V) 
In the prospective cohort studies, person-years of follow-up for each participant were 
calculated from baseline (January 1, 1998), until the date of cataract diagnosis, cataract 
extraction, death or the end of follow-up (Paper III: December 31, 2006; Papers IV and V: 
December 31, 2011), whichever came first. Cox proportional hazards models were used to 
estimate hazard ratios (HRs) and 95% CIs
148
 for cataract associated with dietary supplement 
use (including duration of use) and physical activity (at baseline and long-term). The 
estimates were adjusted for potential confounders, which in Paper III included age, smoking, 
abdominal obesity, educational level, history of hypertension, corticosteroid use, alcohol 
intake, fruit and vegetable intake, physical activity and self-reported health. In Paper IV, the 
model was adjusted for age, smoking status and corticosteroid use. Additional adjustments 
for other potential confounders only changed the risk estimates marginally and were not 
included in the final model. In Paper V, the model was adjusted for age, sex, smoking, 
abdominal obesity, history of hypertension, corticosteroid use, educational level, fruit and 
vegetable intake, antioxidant supplement use, and alcohol intake. Missing values for any of 
the potential confounders were handled in two different ways: either as a separate category in 
the model (missing indicator method; Papers III and V) or excluded from the analysis 
(complete subject analysis; Papers IV and V). The proportional hazard assumption was 
tested by including the product of the exposures of interest and the natural logarithm of time 
in the models and there was no departure from this assumption. 
 
In Paper III, the men were categorized into non-supplement users and users of vitamin C, 
vitamin E or multivitamins only (including both regular and occasional users) or multiple 
supplements in addition to vitamin C or E. In Paper IV, women and men were categorized 
into non-supplement users and users of B vitamins (including vitamin B complex, folic acid 
and vitamin B6) or vitamin B6 only.  
 
Sensitivity analysis was performed to evaluate the potential risk of reversed causality by 
excluding the first 4-7 years of follow-up. In Paper III, correction analyses
149
 were applied 
to examine the effect of misclassification of self-reported supplement use on the risk 
estimates. Assumptions of sensitivity and specificity for the vitamin supplements were based 
on results from a previous validation study in men living in central Sweden.
143
  
 
Stratified analyses were also performed to examine whether the risk between dietary 
supplement use and cataract differed by factors associated with oxidative stress, as well as 
vitamin intake from diet. The likelihood ratio test was used to test for interaction (on the 
multiplicative scale) between these factors and dietary supplement use. In addition, the 
attributable proportion of risk due to interaction (in excess of the additive effects between the 
two exposures of interest), was also calculated in Paper III.
150,151
 Furthermore, in Paper IV, 
the cataract-free survival probabilities over time of follow-up among B vitamin supplement 
users and non-users were derived from Kaplan-Meier curves.  
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The difference in time to event (cataract diagnosis and/or extraction) between B vitamin users 
and non-users was estimated by applying Laplace regression.
152-154
 The 10
th
 percentile of 
survival (corresponds to the point in time when 10% of the group has had an event) was 
modeled in both groups and adjusted for the same covariates as in the proportional hazard 
multivariable model.  
 
In Paper V, the dose-response relationship between total physical activity as a continuous 
variable and cataract incidence was examined using restricted cubic splines with three knots 
located at 10%, 50% and 90% of the distribution of total physical activity (MET*h/day).
155
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5 RESULTS 
5.1 RELATIONSHIP BETWEEN EXOGENOUS AND ENDOGENOUS 
ANTIOXIDANTS (PAPER I) 
The relationship between plasma carotenoids, fruit and vegetable intake (exogenous 
antioxidants) and plasma EC-SOD activity (endogenous antioxidant enzyme) was examined 
in a cross-sectional study including 95 healthy women and 62 non-healthy women (with a 
history of CVD, diabetes or cancer), randomly selected from the SMC–Clinical. 
Characteristics of the women in the highest and lowest quartiles of the sum of plasma 
carotenoids (including lycopene, lutein/zeaxanthin, α-carotene, β-carotene, and β-
cryptoxanthin) are presented in Table 1, Paper I. Healthy women in the highest quartile of 
plasma carotenoids were statistically significantly younger, had higher education, higher fruit 
and vegetable intake and were more likely to be dietary supplement users, as compared to the 
lowest quartile. Non-healthy women in the highest quartile of carotenoids were younger, had 
lower BMI, higher education, higher serum total cholesterol concentrations and higher fruit 
and vegetable intake than in the lowest quartile.  
 
In healthy women, plasma EC-SOD activity was statistically significantly inversely 
associated with plasma concentrations of α-carotene, β-carotene, β-cryptoxanthin and the sum 
of plasma carotenoids, as well as fruit and vegetable intake (Table 4). Pearson partial 
correlation coefficients ranged from -0.22 to -0.38. No statistically significant correlations 
were observed in non-healthy women. 
 
Table 4. Pearson correlation coefficients of plasma carotenoids, fruit and vegetable intake 
and plasma extracellular superoxide dismutase activity in healthy and non-healthy women    
 Extracellular superoxide dismutase activity (Endogenous antioxidant) 
 Healthy women (n=95) Non-healthy women (n=62)
a
 
Exogenous antioxidants Crude Partial
b
 Crude Partial
b
 
Sum of carotenoids -0.28 (P=0.006) -0.31 (P=0.003) 0.008 (P=0.95) 0.05 (P=0.74) 
Specific carotenoids     
Lycopene  -0.16 (P=0.12) -0.20 (P=0.06) 0.01 (P=0.94) 0.04 (P=0.77) 
Lutein/Zeaxanthin -0.15 (P=0.15) -0.18 (P=0.09) -0.08 (P=0.56) -0.06 (P=0.67) 
α-carotene  -0.24 (P=0.02) -0.22 (P=0.04) 0.11 (P=0.39) 0.14 (P=0.29) 
β-carotene  -0.25 (P=0.01) -0.25 (P=0.02) 0.05 (P=0.69) 0.08 (P=0.58) 
β-cryptoxanthin  -0.22 (P=0.04) -0.23 (P=0.03) -0.04 (P=0.73) -0.01 (P=0.94) 
Fruit and vegetable intake -0.39 (P=0.0001) -0.38 (P=0.0002) 0.06 (P=0.66) 0.08 (P=0.56) 
a
 Women with a history of cardiovascular disease, diabetes or cancer. 
b 
Adjusted for age, BMI, smoking, education, supplement use and serum total cholesterol concentrations. 
 
 
Multivariable regression models were used to calculate adjusted mean plasma EC-SOD 
activity in quartiles of the sum of plasma carotenoids (Figure 7A) and fruit and vegetable 
intake (Figure 7B) separately in healthy and non-healthy women. Healthy women in the 
highest quartile of plasma carotenoids and fruit and vegetable intake had 1.2 U/ml (P=0.01) 
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and 1.8 U/ml (P<0.0001) lower plasma EC-SOD activity, respectively, as compared to 
women in the lowest quartile. In non-healthy women, mean plasma EC-SOD activity was not 
significantly different across levels of plasma carotenoids or fruit and vegetable intake. 
Furthermore, the mean plasma EC-SOD activity was lower in healthy women in the highest 
quartile of plasma carotenoids (1.9 U/ml; P<0.001) and fruit and vegetable intake (2.0 U/ml; 
P<0.001), as compared to non-healthy women in the highest quartile.  
 
 
 
 
 
 
Figure 7.  Mean (±SEM) plasma extracellular superoxide dismutase (EC-SOD) activity in 
quartiles (Q) of A) sum of plasma carotenoids and B) fruit and vegetable intake, in healthy 
women, n=95 (dashed line), and non-healthy women, n=62 (filled line). Estimated from a 
multivariable regression model. The numbers in the graphs represent the mean values in each 
quartile. *P<0.02 vs. Q1 in healthy women (Student’s t-test). **Q3: P<0.05; Q4: P<0.001 
difference between healthy and non-healthy women (Student’s t-test). 
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5.2 SYSTEMIC OXIDATIVE STRESS, INFLAMMATION AND CATARACT 
(PAPER II) 
This case-control study nested within the SMC included 258 women (cases) with incident 
age-related cataract diagnosis and/or cataract extraction and 258 women (controls) without 
cataract randomly selected and matched on age and date of urine sample collection. The cases 
were more likely to be corticosteroid users and to have a history of diabetes than the controls 
(Table 1, Paper II). The mean urinary 8-iso-PGF2α (biomarker for systemic oxidative stress) 
level was higher in cases than controls (0.49±0.20 vs. 0.46±0.19 nmol/mmol creatinine; 
P=0.13). Urinary 15-keto-dihydro-PGF2α (biomarker for systemic inflammation) levels did 
not differ between cases and controls. The ORs for cataract according to levels of urinary 8-
iso-PGF2α were derived from a restricted cubic spline model (Figure 8). The risk of cataract 
seemed to increase with higher levels of 8-iso-PGF2α.  
 
 
 
 
Figure 8. Multivariable-adjusted odds ratios and 95% confidence intervals for age-related 
cataract according to levels of urinary 8-iso-prostaglandin F2α. Data were fitted using a 
conditional logistic regression model. 8-Iso-prostaglandin F2α was modeled using restricted 
cubic splines. The histogram shows the distribution of 8-iso-prostaglandin F2α levels in the 
study population. 
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The ORs for cataract by median and quartiles of 8-iso-PGF2α and 15-keto-dihydro-PGF2α 
levels are presented in Table 5. Women with urinary 8-iso-PGF2α levels above median (>0.42 
nmol/mmol creatinine) had a statistically significantly 51% increased odds of cataract as 
compared to those below median and after adjusting for potential confounders (OR=1.51; 
95% CI: 1.03-2.20). In a sensitivity analysis (Table 3, Paper II) including only women 
without a history of diabetes or CVD and not using corticosteroids, similar results were 
observed (the OR for women with 8-iso-PGF2α levels above median compared to below 
median was 1.64; 95% CI: 1.01-2.68). No associations were observed for urinary 15-keto-
dihydro-PGF2α and cataract.  
 
Table 5. Odds ratios
a 
for levels of urinary 8-iso-prostaglandin F2α and 15-keto-dihydro-
prostaglandin F2α and risk of cataract (n=516)  
 No. of cases/ 
controls 
Crude OR (95% CI) Multivariable
b
 OR (95% CI) 
8-Iso-PGF2α (nmol/mmol 
creatinine) 
   
≤Median (≤0.42) 116/142 1.00 (ref.) 1.00 (ref.) 
>Median (>0.42) 142/116 1.57 (1.08-2.27) 1.51 (1.03-2.20) 
    
Quartile 1 (<0.34)  58/71 1.00 (ref.) 1.00 (ref.) 
Quartile 2 (0.34-0.42) 58/71 1.04 (0.62-1.75) 1.00 (0.58-1.73) 
Quartile 3 (0.42-0.55) 72/57 1.60 (0.95-2.68) 1.52 (0.89-2.59) 
Quartile 4 (>0.55) 70/59 1.60 (0.92-2.78) 1.48 (0.83-2.66) 
P-trend  P=0.047 P=0.09 
    
15-Keto-dihydro-PGF2α 
(nmol/mmol creatinine) 
   
≤median (≤0.16) 127/131 1.00 (ref.) 1.00 (ref.) 
>median (>0.16) 131/127 1.07 (0.75-1.51) 1.12 (0.78-1.62) 
    
Quartile 1 (<0.11) 66/63 1.00 (ref.) 1.00 (ref.) 
Quartile 2 (0.11-0.16) 61/68 0.86 (0.54-1.38) 0.79 (0.48-1.30) 
Quartile 3 (0.16-0.22) 64/65 0.94 (0.57-1.55) 0.99 (0.59-1.66) 
Quartile 4 (>0.22) 67/62 1.04 (0.64-1.69) 1.00 (0.60-1.66) 
P-trend  P=0.76 P=0.80 
Abbreviations: CI, confidence interval; OR, odds ratio; PGF2α, prostaglandin F2α. 
a 
Calculated using conditional logistic regression model. 
b
 Adjusted for body mass index, smoking, education, use of corticosteroids, history of diabetes and history of 
cardiovascular disease.
  
 
  
  31 
5.3 DIETARY SUPPLEMENT USE AND CATARACT  
5.3.1 Vitamin C, vitamin E and multivitamin supplements (Paper III) 
This population-based prospective cohort study included a total of 31,120 men, aged 45-79 
years at baseline. During the follow-up period between 1 January 1998 and 31 December 
2006, 2963cases of incident age-related cataract were identified. In this study population, 
5.3% of the men reported use of vitamin C supplements only, 0.5% use of vitamin E 
supplements only and 11.3% use of multivitamins only. Baseline characteristics by dietary 
supplement use are presented in Table 1, Paper III. 
 
After adjusting for potential confounders, men who used high-dose vitamin C supplements 
only had a 21% increased risk of cataract as compared to non-supplement users (HR=1.21; 
95% CI: 1.04-1.41) (Figure 9). Users of high-dose vitamin E supplements only had a 59% 
increased risk of cataract (HR=1.59; 95% CI: 1.12-2.26). The use of multivitamins only 
(doses close to RDI) was not significantly associated with cataract risk (HR=0.96; 95% CI: 
0.86-1.08). To check for potential reversed causality, the first 4 years of follow-up were 
excluded and the results remained similar for users of vitamin C only (HR=1.28; 95% CI: 
1.07-1.53), vitamin E only (HR=1.62; 95% CI: 1.06-2.48) and multivitamins only (HR=0.90; 
95% CI: 0.78-1.04). In a sensitivity analysis, the HRs were corrected for measurement error 
in self-reported use of supplements and were for vitamin C 3.0, vitamin E 3.2 and 
multivitamins 1.1. 
 
 
 
 
Figure 9. Multivariable-adjusted hazard ratios and 95% confidence intervals for dietary 
supplement use and risk of cataract in men. 
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Among men who took other supplements (one or more) in addition to vitamin C (276 cases) 
or vitamin E (169 cases), the HR was 1.06 (95% CI: 0.93-1.20) and 1.02 (95% CI: 0.87-1.20), 
respectively. 
  
Long-term use of vitamin C supplements only (≥10 years before baseline) was associated 
with a 36% increased risk of cataract, as compared to no supplement use (HR=1.36; 95% CI: 
1.02-1.81) (Figure 10). The difference between the risk estimates for duration of vitamin C 
supplement use was not statistically significant (P=0.71). Analysis of duration of vitamin E 
supplement use only was not available due to few cases. The use of multivitamins only ≥10 
or <10 years before baseline was not associated with cataract risk. 
 
 
 
 
Figure 10. Multivariable-adjusted hazard ratios and 95% confidence intervals for duration of 
dietary supplement use (<10 and ≥10 years before baseline) and risk of cataract in men. 
 
A stronger positive association between use of vitamin C supplements and risk of cataract 
was observed among older men (>65 years) and users of corticosteroids (Table 6). The 
attributable proportion due to interaction was borderline statistically significant for age and 
statistically significant for corticosteroid use on the additive scale. However, no statistically 
significant interactions were observed on the multiplicative scale. No statistically significant 
interaction (neither on the additive; all 95% CIs for interaction including 0, nor the 
multiplicative scale; all P for interaction >0.8) was observed between other oxidative stress-
related factors, including smoking, abdominal obesity, history of hypertension and vitamin C 
from diet, and vitamin C supplement use. Since there were too few cases, potential interaction 
between use of vitamin E supplements and oxidative stress-related factors was not examined.  
Vitamins C or E intake from diet only among non-users was not associated with cataract risk. 
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Table 6. Multivariable-adjusted hazard ratios and 95% confidence intervals for vitamin C 
supplement use and risk of cataract by subgroups of age and corticosteroids 
Subgroups No supplement use 
(n=22,015) 
 Vitamin C Only  
(n=1652) 
AP due to 
interaction
a
 
 
 
No. of 
cases 
HR
b 
(95% CI)  No. of 
cases 
HR
b 
(95% CI) 
Age       
≤65 y (n=18,311) 804 1.00 [Reference]  63 1.07 (0.83-1.38)  
>65 y (n=5356) 1133 1.48 (1.14-1.91)  125 1.92 (1.41-2.60) 0.19 (-0.01-0.40) 
Corticosteroid use 
      
No (n=16,270) 1283 1.00
 
[Reference]  123 1.18 (0.98-1.42)  
Yes (n=1942) 239 1.33 (1.16-1.53)  31 2.11 (1.48-3.02) 0.29 (0.01-0.56) 
Abbreviations: AP, attributable proportion; CI, confidence interval; HR, hazard ratio. 
a
 The attributable proportion of risk due to interaction (in excess of the additive effects between the 2 
exposures) and the corresponding 95% CI.  
b 
Adjusted for age, smoking, abdominal obesity, educational level, history of hypertension, corticosteroid use, 
alcohol intake, fruit and vegetable intake, physical activity and self-reported health.    
 
 
5.3.2 B vitamin supplements (Paper IV) 
In this prospective cohort study of 10,362 women and 17,973 men, aged 45-83 years at 
baseline, a total of 5761 cases of incident age-related cataract (2677 cases in women and 
3084 cases in men) were identified during follow-up (January 1998-December 2011). Among 
the women, 4.1% reported use of B vitamins only (including vitamin B complex, folic acid 
and vitamin B6) and 2.7% reported use of vitamin B6 only. The corresponding percentages 
among men were 1.4% and 0.8%, respectively. Baseline characteristics by B vitamin 
supplement use are presented in Table 1, Paper IV. 
  
The use of B vitamins only was associated with a 20% increased risk of cataract in women 
(HR=1.20; 95% CI: 1.01-1.42) and a 54% increased risk in men (HR=1.54; 95% CI: 1.22-
1.95), as compared to non-users. Figure 11 shows the HRs and 95% CIs for B vitamin 
supplement use stratified by different age groups (<60, 60-69 and ≥70 years) in women and 
men separately. The use of B vitamins only was statistically significant positively associated 
with risk of cataract in younger age groups (<60 years for women and <70 years for men), but 
not in those ≥70 years (irrespective of sex).  
 
In a sensitivity analysis, the first 4 years of follow-up were excluded to check for potential 
reversed causality and the results remained fairly unchanged; e.g. compared to no supplement 
use, the HR was 1.53 (95% CI: 1.08-2.17) for B vitamin use in women <60 years, and the 
corresponding HR for men was 2.02 (95% CI: 1.25-3.27). 
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Figure 11. Multivariable-adjusted hazard ratios and 95% confidence intervals for B vitamin 
supplement use and risk of cataract by age groups (<60, 60-69 and ≥70 years) in women and 
men. 
 
Laplace regression was applied to estimate the difference in time-to-event of cataract between 
B vitamin users and non-users, adjusted for the same covariates as in the proportional hazard 
multivariable model. The results showed that 10% of the non-users had the event about 10 
years of study entry, while the same proportion (10%) among users of B vitamins had the 
event 1.4 years (95% CI: 0.42-2.41) earlier in women and 2.2 years (95% CI: 0.48-4.00) 
earlier in men. 
 
Further analysis of potential effect modification by factors related to increased oxidative 
stress, such as smoking, corticosteroid use, abdominal obesity, history of hypertension, 
alcohol intake, and B vitamins from diet, showed no statistically significant interaction 
between B vitamin use and any of these factors (all P for interactions >0.08), except for 
smoking in women (P for interaction=0.01) (Table 7). B vitamins from diet were not 
associated with cataract. 
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Table 7. B vitamin supplements and risk of cataract by smoking status 
 B vitamin supplement use 
Subgroups No supplement use (n=9939) B vitamins
a
  (n=423) 
 No. of cases HR
b
 (95% CI) No. of cases HR
b
 (95% CI) 
Women (n=10,362):     
Smoking      
Never (n=5373/6445) 1498 1.00 [Reference] 68  0.98 (0.77-1.25) 
Ever (n=4989/11,528) 1042 1.12 (1.03-2.14) 69  1.68 (1.32-2.14) 
P-value for interaction    0.01 
Men (n=17,973):     
Smoking      
Never (n=5373/6445) 1057  1.00 [Reference] 22  1.75 (1.15-2.66) 
Ever (n=4989/11,528) 1955 1.17 (1.09-1.27) 50 1.72 (1.30-2.29) 
P-value for interaction    0.50 
Abbreviations: CI, confidence interval; HR, hazard ratio. 
a
 B vitamins include vitamin B complex, folic acid and vitamin B6 supplements. 
b
 Adjusted for age and corticosteroid use. 
 
Long-term use (≥10 years before baseline) of vitamin B6 supplements, based on an analysis 
of a small number of cases (27 cases in men and 47 cases in women), was associated with a 
3-fold increased risk of cataract in men (HR=3.28; 95% CI: 1.82-5.93), but not in women 
(Figure 12). Data for duration of use of other B vitamin supplements was not available. 
 
 
 
Figure 12. Multivariable-adjusted hazard ratios and 95% confidence intervals for duration of 
vitamin B6 use and risk of cataract in women and men.  
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5.4 PHYSICAL ACTIVITY AND CATARACT (PAPER V) 
The association between physical activity and risk of age-related cataract was examined in a 
prospective cohort study of 52,660 participants (23,853 women and 28,807 men), aged 45-83 
years at baseline. A total of 11,580 incident cases of age-related cataract were identified 
during follow-up between 1 January 1998 and 31 December 2011. Baseline characteristics by 
quartiles of total physical activity are shown in Table 1, Paper V. 
 
The dose-response relationship between total physical activity and risk of cataract was 
examined using a restricted cubic spline model (Figure 13). Total physical activity was 
inversely associated with cataract risk. There was no evidence of significant departure from 
linearity (P=0.22). Every increment of 4 MET*h/day, which corresponds to 1 h of moderate 
effort, was associated with a 5% reduced risk of cataract (HR=0.95; 95% CI: 0.94-0.97). 
Similar results were observed separately in women (HR=0.96; 95% CI: 0.94-0.98) and in 
men (HR=0.94; 95% CI: 0.92-0.97). Participants in the highest quartile of total physical 
activity had a 13% reduced cataract risk, as compared to those in the lowest quartile 
(HR=0.87; 95% CI: 0.82-0.92) (Figure 14). 
 
 
 
Figure 13. Risk of cataract according to total physical activity. Data were fitted using a 
multivariable-adjusted Cox regression model. Total physical activity was modeled using 
restricted cubic splines (the solid line is the point estimate and dashed lines are 95% 
confidence limits). The long-dashed line represents the linear trend and the reference value is 
37 metabolic equivalent*h/day (median value of the lowest quartile of total physical activity).   
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Figure 14. Multivariable-adjusted hazard ratios and 95% confidence intervals for quartiles 
(Q) of total physical activity and risk of cataract. 
 
Long-term high total physical activity (highest quartile both at age 30 years and at baseline) 
was associated with a 24% reduced risk of cataract, as compared to long-term low total 
physical activity (lowest quartile at both time periods) (Figure 15). 
 
 
 
Figure 15. Multivariable-adjusted hazard ratios and 95% confidence intervals for long-term 
total physical activity and risk of cataract. Long-term total physical activity levels were 
estimated by combining levels (low=quartile 1, Q1 and high=quartile 4, Q4) at age 30 years 
and at baseline.  
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For specific types of physical activity, both walking/bicycling >60 min/day, as compared to 
hardly ever (modifiable), and heavy manual labor, as compared to mostly sitting (less 
modifiable), were associated with 12% and 16% reduced risk of cataract, respectively 
(Figure 16). Exercise training and home/housework were not associated with cataract risk.  
 
 
 
Figure 16. Multivariable-adjusted hazard ratios and 95% confidence intervals for walking/ 
bicycling and work/occupational activity and risk of cataract.  
 
Conversely, leisure time inactivity >6 h/day (as compared to sitting <1 h/day) was associated 
with a 27% increased risk of cataract (HR=1.27; 95% CI: 1.07-1.50) (Figure 17). 
 
 
 
Figure 17. Multivariable-adjusted hazard ratios and 95% confidence intervals for leisure 
time inactivity and risk of cataract.   
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6 DISCUSSION 
6.1 METHODOLOGICAL CONSIDERATIONS 
When interpreting results from observational epidemiological studies, several methodological 
aspects need to be considered, including the study design and random and systematic errors. 
 
6.1.1 Study design 
This thesis is comprised of different types of study designs, including cross-sectional (Paper 
I), nested case-control (Paper II) and prospective cohort studies (Papers III-V). Each study 
design has strengths and limitations. All observational studies have in common that the 
results reflect associations rather than direct evidence/effect or causation.  
 
Paper I is a cross-sectional study, in which the exposures and outcomes are assessed at a 
single point in time. Cross-sectional studies can be used for descriptive purposes and the 
prevalence of a disease can be estimated, but not the incidence, because there is no 
information on time aspect/temporality (i.e. whether the exposure precedes the outcome or 
not). Although it is not possible to directly infer causality, associations observed in cross-
sectional studies can lead to the generation of hypotheses for future studies. 
 
Paper II is a nested case-control study, which includes women with incident age-related 
cataracts as cases, and for each case, one woman without cataract who fulfilled the matching 
criteria and was randomly selected from the SMC-C (as a control). Matching the cases and 
controls on confounding variables, such as age and date of urine sample collection, may be a 
way to increase the efficiency of stratified analysis.
151
 Major limitations of case-control 
studies are that they may introduce selection bias (controls may not be representative of the 
population from where the cases came) and recall bias (cases may tend to recall their 
exposures differently than controls). However, the impact of these biases is eliminated in a 
nested case-control study due to that the cases and controls were from the same study 
population (SMC-C) and information on exposures was prospectively collected (i.e. the FFQ 
and urine sample collection was completed before the incidence of cataract). 
 
Papers III-V are large, population-based prospective cohort studies based on the SMC 
and/or COSM. In prospective cohort studies, the occurrence of a disease can be measured in a 
population/cohort that is disease-free at baseline and followed over a period of time. The 
purpose can be to measure and compare disease occurrence among people who are exposed 
and unexposed. Large cohort studies are suitable to examine multiple exposures and/or 
multiple outcomes, and from this type of study the disease incidence can be calculated. The 
prospective design of a cohort study reduces the risk of different biases, such as selection and 
recall bias. Some limitations of cohort studies are that they are time consuming and expensive 
(without registers). However, the latter is less of a problem with the Swedish health/disease 
registers. 
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6.1.2 Random error  
The precision of a risk estimate, defined as the absence of random errors, is indicated by its 
confidence interval: a narrow interval indicates high precision and a wide interval indicates 
low precision.
151 
In this thesis, 95% confidence intervals were used, which means that if the 
studies (data collection and statistical analysis) were replicated many times, the correct value 
should lie within the confidence interval in 95% of the time. A confidence interval that 
includes the null value (HR=1.00) shows no association, but if it does not include the null 
value it suggests a statistically significant association. The precision may be improved by
 
increasing the sample size.
151
 In this thesis, the main associations observed were statistically 
significant and the study sizes were relatively large and included many cases of cataract, 
especially in Papers III and V, which improved the precision and reduced the risk of 
rejecting the null hypothesis when this was true. However, the precision may be lower in 
some of the subgroup analyses due to a smaller number of cases in the exposure groups. 
 
 
6.1.3 Systematic error 
Systematic error includes different types of biases that can be classified into three categories: 
selection bias, information bias and confounding.
151
 The internal validity of a study is related 
to the biases and the external validity refers to generalizability of the results. 
 
6.1.3.1 Selection bias 
The selection of subjects into a study can lead to selection bias if there are errors in the 
selection procedures or if some factors influence the participation. In cohort studies, selection 
bias may occur if an association observed for an exposure and an outcome differs between 
study participants and non-participants. The presence of selection bias is difficult to assess 
since exposure and outcome information is usually unknown for non-participants.
151 
Self-
selection, or the “healthy worker effect”, is a type of selection bias, which means that the 
individuals who agree to participate in a study are different in some aspects from those who 
do not want to participate, for example by being more health conscious and therefore more 
interested to participate. It may lead to a lower observed disease rate than expected. On the 
other hand, it may also be possible that individuals with poorer health want to participate, 
since they are more worried and at higher risk of developing a disease, which may lead to a 
higher observed disease rate. The net effect of the bias would be unknown, since it is difficult 
to quantify the biases. Selection bias may also occur due to differences between exposed and 
unexposed with regard to loss of follow-up. In this thesis, the studies are based on large, 
population-based prospective cohorts with a high response rate for the women in the SMC of 
74% and a response rate for the men in the COSM of 49%. The prospective design of the 
studies reduces the risk of selection bias. Moreover, follow-up of the SMC and COSM is 
almost complete, because of the linkage to various high-quality population-based Swedish 
health/disease registers.     
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6.1.3.2 Information bias 
Information bias refers to errors in the measurement of a variable, leading to misclassification 
of exposure and/or outcome. For example, one person can be categorized incorrectly due to 
erroneously information collected. Misclassification can be classified into differential or non-
differential for both exposures and outcomes. Misclassification is affected by the sensitivity 
and specificity of a method used to identify or measure the exposure and/or outcome. If the 
misclassification of an exposure is unrelated to the occurrence of an outcome, then it is non-
differential. On the other hand, if the exposure misclassification differs between those with 
and without the outcome, then it is differential. The same applies for outcome 
misclassification related to the exposure. Non-differential misclassification of a dichotomous 
variable tends to dilute the observed association towards the null/no-effect value.
151
 
Differential misclassification can lead to either overestimation or underestimation of an 
association. A typical type of information bias that leads to differential misclassification is 
recall bias, which occurs in case-control studies in circumstances where the cases tend to 
recall exposure information differently than the controls. The risk of recall bias is, however, 
minimized in the papers included in this thesis, due to the prospective design where exposure 
information was collected before the identification of outcome/incidence of cataract. 
 
In Papers I and II, biomarkers of antioxidants and oxidative stress were measured, which is 
a more objective way to assess exposures than using self-administered questionnaires and 
may reduce the risk of misclassification, if laboratory analyses are performed carefully. There 
are, however, some factors that may lead to misclassification in biomarker measurement, 
such as the timing of sample collection and storage, stability of the measured biomarkers, and 
potential laboratory errors. To reduce the risk of misclassification, the samples in the studies 
were collected at the same time (in the morning) and stored at -80 °C. Enzyme activity (e.g. 
EC-SOD activity) can be difficult to measure, since assays may be sensitive to a number of 
factors, such as temperature, time and pH. Therefore, it is important to be as consistent and 
careful as possible during the laboratory analysis (e.g. control samples for each plate were 
analyzed in the EC-SOD assay). Samples and standards were analyzed in duplicate to 
decrease the risk of non-differential misclassification, and the inter- and intra-assay 
coefficients of variations were calculated. The biomarkers chosen for systemic oxidative 
stress and inflammation were considered to be reliable and stable over time, and were 
analyzed using previously validated methods.
8,137
  
 
The exposures in Papers III-V (dietary supplement use and physical activity) were assessed 
using a self-administered questionnaire completed by the study participants at recruitment. 
People may recall and estimate their habits differently (inter-person variability). However, 
due to the prospective design of the studies (data collection precedes the identification of 
outcome), potential misclassification of the exposures is likely to be non-differential (i.e. 
unrelated to the incidence of age-related cataract). However, cataract may develop slowly and 
there is a possibility that participants may change their diet and lifestyle habits due to some 
early symptoms, which may lead to differential misclassification. For example, if people with 
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early eye symptoms start to take dietary supplements, the observed association may be due to 
reverse causality. In Papers III-V, the first 4-7 years of follow-up were excluded in the Cox 
proportional hazards models in sensitivity analysis and the risk estimates were similar to 
those in the main analyses, suggesting that reverse causality is unlikely to explain the 
observed findings. The sensitivity and specificity of dietary supplement use have been 
examined in a validation study of men living in central Sweden and were shown to be 
relatively high for vitamin C (0.7 and 0.9), vitamin E (0.8 and 0.99) and multivitamins (0.7 
and 0.98).
143
 The physical activity questions in the questionnaire have also been validated 
against 7-day activity records in both cohorts and appear to estimate total physical activity 
satisfactory (Spearman’s rank correlation: 0.6).145,146  
 
There could also be misclassification of the outcome (cataract diagnosis and/or cataract 
extraction). Since lens opacities can occur without symptoms and there is a lack of 
standardized eye examinations in the cohorts, an underestimation of cases is possible. This 
under-ascertainment of cases is likely to be non-differential (unrelated to the exposures). 
However, there is also the possibility that participants who are more health conscious may 
seek medical care earlier for visual complaints and are also more likely to use dietary 
supplements or be physically active. On the other hand, participants with poorer overall 
health may also seek medical care earlier and may use dietary supplements more often due to 
suboptimal/limited nutritional intake. This would affect the risk estimates in either direction. 
However, since everyone has the same affordable access to cataract extractions in the 
Swedish health care system (patient charge of <$50/surgery), seeking medical help may not 
depend on socioeconomic factors. 
 
6.1.3.3 Confounding 
When interpreting results from observational studies, one has to consider if the observed 
association may be explained by a third factor, a confounder, which is a variable that is 
related to both the exposure and the outcome of interest, without being an intermediary step 
in the causal pathway.
151 
The possible effects of confounding may include that the whole or 
part of an association is accounted for by the confounding factor(s), leading to overestimation 
or underestimation of the true association. Confounding can be handled in different ways, for 
example by including potential confounders as covariates in a statistical model, using 
restrictions (excluding participants with certain characteristics at baseline) or through 
randomization (in experimental studies). Randomization of the exposure variable (used in 
RCTs) is an efficient way to prevent known and unknown confounding. However, the 
efficacy of the randomization may depend on the size of the study population. If the study 
population is sufficiently large, the randomization process should produce experimental 
groups with almost the same distribution of characteristics.
151
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In this thesis, confounding was controlled for by including covariates in statistical models and 
through restrictions. Since those who used dietary supplements and/or had a high physical 
activity levels may be more health conscious, this could influence our observed associations. 
To address this issue, the statistical models were adjusted for several potential confounders, 
including demographic, medical, lifestyle and dietary factors. The main results remained 
similar when comparing the crude and adjusted risk estimates. Furthermore, in the cohort 
studies (Papers III-V), participants with a history of CVD, diabetes and cancer were 
excluded, to avoid potential confounding by these diseases on diet and lifestyle-related 
changes.  
 
Although attempts have been made to control for confounding in our observational studies, 
the possibility that the findings may be influenced by residual confounding cannot be ruled 
out. Residual confounding is the confounding that remains after adjustments have been made, 
and it can be caused by unmeasured factors/confounders, imprecise data or misclassification 
of the confounding variables. 
 
6.1.3.4 Generalizability 
In this thesis, the papers are based on two large, population-based, prospective cohort studies 
of middle-aged and elderly women and men from central Sweden. The participants were 
recruited from the general population living in specific geographic areas. They appear to well 
represent the Swedish population of middle-aged and elderly persons during the study period, 
since distributions of several demographic and lifestyle factors, such as age, smoking habits, 
body mass index and education level, are similar to the Swedish population.
156,157
 The results 
in this thesis may therefore be generalizable to middle-aged and elderly women and men in 
Sweden and other similar countries. However, the generalizability may be limited in younger 
populations and populations with other ethnicities.  
 
6.2 MAIN FINDINGS AND INTERPRETATIONS 
6.2.1.1 Relationship between exogenous and endogenous antioxidants (Paper I) 
Results from Paper I showed that high levels of exogenous/dietary antioxidants including 
plasma carotenoids and fruit and vegetable intake were associated with lower plasma EC-
SOD activity (endogenous antioxidant enzyme) in healthy women. However, no association 
was observed in women with a history of chronic diseases, such as CVD, diabetes or cancer.  
 
Few previous studies have investigated the association of fruit and vegetable intake or blood 
concentrations of carotenoids with plasma EC-SOD activity. One cross-sectional study 
observed a non-significant inverse association between plasma EC-SOD activity and 
carotenoids in a healthy population.
158
 Another study found a weak positive correlation; 
however, the sum of serum carotenoids was measured at baseline and EC-SOD activity was 
collected and measured 15 years later.
159
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The biological mechanism behind the inverse association observed in healthy women is 
unclear. It could be speculated that high levels of exogenous/dietary antioxidants may lead to 
a compensatory down-regulation of EC-SOD activity. Experimental studies have shown that 
plasma carotenoids may be involved in different transcription systems, thereby influencing 
the expression of antioxidants.
50,160
 In humans, high concentrations of blood carotenoids have 
also been related to lower oxidative damage.
158
 However, more studies are needed to examine 
the mechanisms by which carotenoids may potentially influence EC-SOD activity.  
 
In women with a history of CVD, diabetes or cancer, no inverse association between the 
antioxidants was observed, suggesting that plasma EC-SOD activity may not be down-
regulated with increasing exogenous/dietary antioxidants in the presence of disease. This may 
potentially be due to higher systemic oxidative stress and inflammation levels. Moreover, the 
mean plasma EC-SOD activity in the highest quartiles of plasma carotenoids and fruit and 
vegetable intake was statistically significantly higher in non-healthy women than in healthy 
women, which suggests a potential up-regulation of the enzyme.
161
 Animal studies have 
shown a protective role of EC-SOD in vascular function and blood pressure regulation.
162-167
 
However, human studies have shown inconsistent results for EC-SOD activity in association 
with CVD. Some studies observed an up-regulation of EC-SOD activity in CVD patients as 
compared to healthy controls,
47,161,168-170
 while others observed no difference,
49,168
 or 
decreased
48
 activity. Human studies have also observed statistically significantly higher 
serum EC-SOD activity in patients with type II diabetes than healthy controls.
168-170
 
    
6.2.1.2 Systemic oxidative stress, inflammation and age-related cataract (Paper II) 
This nested case-control study (Paper II) indicates that higher levels of urinary 8-iso-PGF2α 
(a biomarker of systemic oxidative stress), but not 15-keto-dihydro-PGF2α (a biomarker of 
systemic inflammation), were associated with increased risk of age-related cataract in 
women. These results are in line with previous studies in humans showing increased 
oxidative stress levels both in the lens
65,171
 and systemically.
75-79
 However, previous studies 
have only measured 8-iso-PGF2α in blood and not in urine, and no studies have assessed the 
association of 15-keto-dihydro-PGF2α and risk of cataract. Urinary 8-iso-PGF2α may be a 
more suitable biomarker for studying chronic diseases, since it reflects a longer-term 
exposure than blood.
8,137
 Only one case-control and one cross-sectional study have previously 
investigated levels of 8-iso-PGF2α (in plasma) and risk of cataract.
75,79
 The cross-sectional 
study (n=27 participants with early cataract and n=13 participants without cataract) did not 
observe any difference in plasma 8-iso-PGF2α levels, although there was increased levels of 
another lipid peroxidation biomarker, hydroxyoctadecadienoic acid, in participants with 
cataract.
75
 The case-control study (n=102 cases and n=102 controls) observed statistically 
significantly higher levels of plasma 8-iso-PGF2α in cataract patients as compared to controls, 
matched on age and gender.
79
 Other case-control studies have observed increased blood 
levels of other biomarkers for lipid peroxidation and oxidative stress, such as 
malondialdehyde, in cataract patients as compared to age-matched controls.
76-78
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In this study, urinary 15-keto-dihydro-PGF2α was not associated with age-related cataract. 
This is in line with two cross-sectional studies that observed no association between systemic 
inflammation biomarkers (as measured by serum C-reactive protein, an acute-phase protein) 
and cataract in humans.
81,82
 However, one of the studies observed a positive association 
between the inflammatory biomarker serum interleukin 6 and prevalence of nuclear 
cataract.
81
 Moreover, a case-control study nested within the Physicians Health Study I 
observed a positive association between C-reactive protein levels and cataract in apparently 
healthy male physicians (n=834 of which 143 men developed cataract).
80
 However, since 
different biomarkers have been used to measure systemic oxidative stress and inflammation, 
and the lack of standardized methods, the comparability between studies may be limited.
172  
 
The potential mechanisms underlying the observed findings may be linked to some of the risk 
factors for cataract, such as age, diabetes and use of corticosteroids.
5
 Since these factors are 
often associated with increased generation of ROS and lipid peroxidation products in vivo, 
especially in the lens,
65,171
 they may also be related to systemic oxidative stress and increased 
urinary 8-iso-PGF2α levels.  
 
6.2.1.3 Dietary supplement use and cataract (Papers III and IV) 
Results from the large, population-based prospective cohort studies of dietary supplement use 
(Papers III and IV) suggest that the use of single, high-dose supplements of vitamin C, 
vitamin E or B vitamins, but not multivitamins (estimated to usually contain nutrient doses 
close to RDI), was associated with increased risk of cataract. The results also suggest that for 
vitamin C supplements, the risk may be even higher in older men, corticosteroid users, and 
long-term users. The positive association observed between B vitamins and cataract seemed 
to be stronger in younger participants (<60 y). 
 
The results for high-dose vitamin C supplements confirm findings from a previously 
published study of women from the SMC (n=24,593).
102
 However, observational studies have 
in general shown inconsistent results regarding the use of dietary supplements, including 
vitamin C, vitamin E, B vitamins and multivitamins (previously reviewed by Mares
90,91
 and 
Seddon,
92
 and summarized in Table 2).
84,87,93-102
 RCTs have mostly shown no effect of high-
dose dietary supplements, given either individually or in a combination, for cataract 
prevention, except one study
103
 that reported a deceleration in cataract progression for a 
combination of antioxidants (previously reviewed by Mares,
90,91
 Mathew
104
 and Chew,
105
 and 
summarized in Table 3).
103,106-113
 These results are in line with several other large RCTs 
investigating the effect of single, high-dose vitamin/antioxidant supplements for prevention 
of other chronic diseases that also have failed to show any protective effect.
117-121 
Indeed, 
some RCTs have even reported harmful effects of high-dose antioxidant supplements for 
CVD,
122
 some types of cancers
123-125 
and mortality.
126
 On the other hand, three RCTs have 
reported a modestly decreased risk of total and nuclear cataract for multivitamins containing 
doses close to RDI. One of the trials (the Linxian Cataract Studies) was based on a study 
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population with micronutrient deficiencies at baseline.
114
 The other two trials were conducted 
among generally well-nourished study populations (the Italian-American Clinical Trial of 
Nutritional Supplements and Age-Related Cataract and the Physicians’ Health Study II).115,116  
 
One interesting and important question to discuss is why antioxidants from dietary sources 
seem to be protective against chronic diseases (mainly observed in observational studies), 
while the use of dietary supplements have mainly failed to show protective effects 
(inconsistent results in observational studies and mostly no effects in RCTs)? There are 
several possible explanations for these observations. First, from a biological point of view, 
antioxidant-rich sources, such as fruit and vegetables, may include a variety of 
nutrients/components that act in a complex manner (e.g. synergistically). Therefore, intake of 
a single nutrient separated from the food source and provided at relatively high 
concentrations may not contribute to the same physiological effects. Moreover, since 
different exogenous/dietary antioxidants may have different antioxidant properties and may 
be involved in redox cycling of other antioxidants, providing only one single antioxidant (e.g. 
one isoform of a vitamin) may disturb the redox balance and in some cases lead to pro-
oxidative effects (e.g. for vitamin C and E). Furthermore, the bioavailability of a nutrient may 
be different depending on intake from either a natural food source or in dietary supplement 
form. Second, from a methodological point of view, differences between studies in multiple 
aspects related to study design make the comparability between studies limited.  
 
The following factors may influence the comparability of results between studies:  
 Study design: observational or intervention? 
 Type of supplement(s) used: single or multiple? 
 Dosage: RDI or high-dose? 
 Duration: short-term or long-term? 
 Antioxidant status at baseline: deficiency or adequate nutritional status? 
 Health status at baseline: primary or secondary prevention? 
 Outcome: cataract diagnosis or cataract extraction (information on subtypes)? 
 
It is important to consider these factors when interpreting results from different studies. 
Observational studies measure associations rather than causation and the possibility of 
residual confounding cannot be ruled out, which may influence the observed associations 
between dietary supplement use and risk of cataract. However, this is generally not an issue 
in a well-designed RCT, which is considered as the “golden standard” (providing most 
convincing evidence). The type, dose, and duration of supplement use are other aspects to 
consider when interpreting results from different studies. For example, there is a large 
variation in the dose and duration of vitamin C and vitamin E supplements used in RCTs 
(summarized in Table 8). Of note, some trials have used vitamin doses that exceeded the 
“safe”/upper tolerable limits as recommended by the European Food Safety Authority.173 
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Moreover, baseline antioxidant status may also be important, since the supplementation of 
antioxidants may to be more efficient if given to a population with baseline deficiencies, 
which was the case for the Linxian Cataract Studies (RCTs).
111,112
 The health status of the 
study population may also influence the results, for example the populations of two other 
large RCTs were based on physicians and nurses, which are considered to generally be more 
health conscious and well-nourished. Only 3-4% of participants were current smokers among 
the physicians,
112
 as compared to 24% among the men in the COSM. Furthermore, the 
outcome used to assess cataract differs between studies. In our studies, cataract diagnosis and 
cataract extraction were defined as the outcome, but we did not have information on grade or 
subtypes of cataracts, which some studies had, while other studies only included cataract 
extraction or one subtype. Another factor is difficulty in translating results from animal 
experiments into recommendations for humans. Since it is difficult to obtain and study 
cataract lenses from humans, several experimental animal models have been developed, but 
the human lens differs from animal experiment lenses in several aspects, including levels of 
oxidation with age, endogenous antioxidant enzymes, vitamin C synthesis, protein content, 
etc.
53 
 
 
Table 8. The dose and duration of vitamin supplements used in RCTs for cataract prevention 
Antioxidants Dose (range)
a
 Duration (range)
a
 Recommended 
Daily Intake
b
 
Upper Tolerable 
Limit
b
 
Vitamin C 120-750 mg/day 3-8 years 75 mg/day - 
Vitamin E 30-600 mg/day 3-10 years 8-10 mg/day 300 mg/day
c
 
a
 From references 103, 107, 110, 112 and 114 (vitamin C); 103, 106, 107 and 109-114 (vitamin E). 
b
 Recommendations for adults: women/men (Source: Nordic Nutrition Recommendations 2012).
20
 
c
 From supplements (Source: European Food Safety Authority 2003).
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The biological mechanisms behind our findings are not fully understood. The mechanisms 
could be related to disturbed redox homeostasis and pro-oxidative properties of single, high-
dose vitamins/antioxidants, which have been shown in experimental studies using large doses 
of vitamin C, vitamin E or B vitamins.
32,33,41,53,174-178
 The use of a single high-dose 
antioxidant supplement, such as for vitamin E supplements where the commonly used 
isoform is α-tocopherol, may reduce the uptake of other natural forms of vitamin E at high 
concentrations.
179
 The statistically significant interaction observed between use of vitamin C 
and older age, as well as corticosteroids, may involve an inflammatory mechanism and 
increased oxidative stress.
80
 Both aging and the use of corticosteroids are risk factors for 
cataract.
180
 The use of corticosteroids may also indicate an underlying illness associated with 
increased oxidative stress and inflammation.
181
 However, the association between B vitamins 
supplements and risk of cataract seemed to be stronger in the younger age groups. The 
mechanism for this association is unclear. We can only speculate that it could be related to a 
relatively high prevalence of inadequate B vitamin status, which has been observed in some 
elderly populations.
10
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The results from Paper III and IV add to the accumulating evidence from other recent 
studies also showing potentially harmful effects of single, high-dose antioxidant supplements 
in the general population. They underscore the need to consider with caution use of high-dose 
supplements or unregulated supplements with uncontrolled dosages. However, the use of 
multivitamins was not associated with cataract risk in our study. Three RCTs have suggested 
a potential protective effect of multivitamins for nuclear cataract development, but this effect 
was countered by a potentially harmful effect for posterior subcapsular cataract development, 
as observed in one of the trials.  
 
6.2.1.4 Physical activity and cataract (Paper V) 
In this thesis, results showed that high total physical activity levels and specific types of 
physical activity, including walking/bicycling and work/occupational activity, were 
statistically significantly associated with decreased risk of age-related cataract in women and 
men. The inverse association seemed to be even stronger with long-term consistently high 
total physical activity levels, both during young adulthood (age 30 years) and later on in life. 
Leisure time inactivity was positively associated with risk of cataract.  
 
These population-based results are in line with the three previous studies that have examined 
the association between physical activity and risk of cataract in selected physically active 
populations
133,134
 or at a hospital setting.
135
 Two prospective cohort studies based on the 
National Runners’ and Walkers’ Health Studies, observed that moderate (walking) and 
vigorous (running) physical activity, but not other moderate-intensity exercise, were 
associated with similar decreased risk of cataract in women and men.
133,134
 Of note, the 
recruitment of participants in these cohorts was conducted among subscribers of activity-
targeted publications and participants at footrace events, and therefore included more 
physically active participants than a general population. Moreover, a small case-control study 
(n=110 cataract cases and n=50 age-matched hospital controls) observed a 4-7 fold higher 
odds ratio for cataract in patients with low physical activity as compared to high physical 
activity.
135
 This study was conducted in a hospital setting and the ORs were adjusted only for 
age.
135
 To our knowledge, our study was the first to prospectively examine the association 
between physical activity, including total and specific subtypes and duration, and risk of 
cataract in a population-based study. 
 
Potential biological mechanisms behind the findings may involve reduced oxidative stress 
and inflammation levels, as well as improved insulin resistance and lipid profiles.
127-129
 Long-
term, high physical activity levels in elderly people have been associated with higher total 
antioxidant capacity and lower oxidative damage.
129
 During physical activity/muscle 
contractions, there is a mild pro-oxidative state, which triggers some of the beneficial effects 
of exercise, including signaling processes for muscle adaptation and increased expression of 
antioxidant enzymes.
182
 Moreover, physical activity may also reduce inflammation (as 
measured by C-reactive protein)
183
 and improve the lipid profile by elevating high-density 
  49 
lipoprotein-cholesterol and lowering triglyceride concentrations.
184
 Hypertriglyceridemia has 
been positively associated with risk of posterior subcapsular cataract.
185
 Other beneficial 
health effects of physical activity include improved insulin resistance
3
 and decreased risk of 
diabetes and hypertension,
130
 which are suggested risk factors for cataract.
5
 On the other 
hand, high levels of physical inactivity may lead to increased ROS production, endothelial 
dysfunction and atherosclerosis in mice,
131
 and increased protein oxidation and lipid 
peroxidation in humans.
186
 The inverse association observed for long-term total physical 
activity and the lack of association for leisure time exercise with cataract risk suggest that 
being physically active on a regular daily basis as reflected by long-term total physical 
activity, in contrast to short weekly episodes of exercising/training, may contribute to cataract 
prevention. Home/housework was not associated with risk of cataract, potentially due to a 
large variation in the different types of tasks and activity levels performed. 
 
In summary, the results in Paper V are in accordance with the inverse association observed 
between physical activity and risk of many other chronic diseases, such as CVD and type II 
diabetes, and further add to the knowledge of health benefits of physical activity. 
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7 CONCLUSIONS 
Results from the papers included in this thesis showed that:  
 
 High levels of exogenous/dietary antioxidants, namely plasma carotenoids and intake 
of fruit and vegetables, were associated with lower plasma EC-SOD activity 
(endogenous antioxidant enzyme) in healthy women. This association was, however, 
not observed in women with a history of CVD, diabetes or cancer.   
 
 Systemic oxidative stress (as measured by urinary 8-iso-prostaglandin F2α) was 
associated with increased risk of age-related cataract in women. However, no 
association was observed between systemic inflammation (as measured by urinary 
15-keto-dihydro-prostaglandin F2α) and risk of cataract.  
 
 In a generally well-nourished population, the use of high-dose vitamin C or vitamin E 
supplements was associated with increased risk of cataract in men. However, the use 
of low-dose multivitamins was not associated with risk of cataract. 
 
 The use of high-dose B vitamins supplements was associated with increased risk of 
cataract in women and men. 
 
 High levels of total physical activity, especially long-term, as well as specific types 
such as walking/bicycling and work/occupational activity, were associated with 
decreased risk of cataract in women and men. On the other hand, high leisure time 
inactivity was associated with increased risk of cataract.  
 
 
 
In summary, these results suggest that maintaining low levels of systemic oxidative stress 
by having a healthy lifestyle, for example eating an antioxidant-rich diet including plenty of 
fruits and vegetables instead of taking dietary supplements and being physically active on a 
regular basis may contribute to the prevention of age-related cataract in the general 
population. 
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8 FUTURE RESEARCH 
The results from this thesis have added small pieces of evidence to the complex field of 
oxidative stress research and contributed to the knowledge about the association between 
oxidative stress and age-related cataract. To further deepen and extend our understanding of 
the interplay between antioxidants, reactive species and oxidative stress, and for prevention of 
cataract, future studies could benefit from improved methodology for exposure and outcome 
assessments.  
 
Since the relationship between exogenous/dietary antioxidants and endogenous antioxidants 
may differ depending on the health status of the individual, it may be of importance to 
examine the associations between different antioxidants, as well as biomarkers of oxidative 
stress, separately in populations/ subgroups depending on health status to better understand 
their interplay. In future observational studies, it would be interesting to examine the 
association between different exogenous/dietary and endogenous antioxidants and systemic 
oxidative stress in people “at risk” of developing or who already have age-related cataract. 
This could contribute to our understanding of whether specific antioxidants levels may be 
altered and which potential antioxidant and oxidative stress biomarkers are most relevant to 
cataract development.   
 
The choice of appropriate biomarkers for measuring oxidative stress and inflammation status 
is an important aspect to consider. Are the chosen biomarkers reflecting acute or chronic 
oxidative stress/inflammation? Are the biomarkers useful for prediction or progression of a 
disease? In this thesis, the risk of cataract was examined using urinary 8-iso-prostaglandin F2α 
and 15-keto-dihydro-prostaglandin F2α as biomarkers of systemic oxidative stress and 
inflammation. Although these are generally considered stable and reliable biomarkers, there 
may be other more sensitive biomarkers that could better reflect the systemic oxidative stress 
or inflammation associated with cataract. Since different studies have used different 
biomarkers of oxidative stress and inflammation, it is difficult to compare the results between 
the studies. Moreover, it may also be difficult to compare results from studies using the same 
biomarker, because the laboratory methods used may differ, as well as the type of biological 
samples used (e.g. urine or blood samples). Therefore, to better enable comparison between 
studies and to confirm our observed association of urinary 8-iso-prostaglandin F2α and risk of 
cataract, there is a need for standardized methods for measuring oxidative stress status in 
vivo, including reference values (ranges) according to characteristics, such as age and type of 
samples analyzed. 
 
In this thesis, the use of multivitamins (with doses close to RDI) was not associated with risk 
of cataract. Moreover, the use of single, high-dose antioxidant supplements was associated 
with increased risk of cataract. These studies were based on generally well-nourished 
populations and therefore, a potential explanation for the lack of a protective association may 
be that increasing the intakes of single antioxidants may not provide further health benefits 
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among people who already have optimal nutritional status. Potential beneficial effects of 
multivitamins (with doses close to RDI) have been reported in some other studies and in 
populations with baseline micronutrient deficiencies. Therefore, future observational and 
experimental studies may consider examining the use of low-dose (close to RDI) 
multivitamins (or a combination of other low-dose antioxidants) for the prevention of chronic 
diseases, such as cataract, in “high-risk” populations, for example those with low antioxidant 
intake and that are at risk of developing or already have micronutrient deficiencies. To 
identify the populations that would benefit the most from dietary supplements, it may be 
important to measure systemic oxidative stress levels in vivo in addition to antioxidant status. 
In future observational studies, to improve exposure assessment of antioxidant status, it could 
be useful to combine information on antioxidant intake from self-administered FFQs with 
related biomarkers (that change with dietary intake) preferably using repeated/multiple 
measurements reflecting long-term status. For future RCTs, which is the type of study that 
can provide the most convincing evidence, focus could be on the optimal composition, dose 
and duration of dietary supplements to prevent eye diseases and maintain health. In addition, 
measurements of in vivo oxidative stress biomarkers before and after an intervention may also 
be valuable to address whether the supplement(s) given has changed oxidative stress levels, 
which may in turn be related to the risk of cataract. 
 
The protective association observed between physical activity and risk of cataract in our 
Swedish population-based prospective cohorts needs to be confirmed in other populations. 
Future studies may include large, prospective cohort studies using validated questionnaires 
and/or instruments to measure physical activity and taking into account which type, intensity 
and duration of physical activity may contribute the most to cataract prevention.  
 
The ascertainment of cataract cases should also be improved in future studies. For the studies 
included in this thesis, cataract diagnosis and/or cataract extraction were used as the outcome. 
Cataract grades and subtypes were not examined, due to lack of standardized eye 
examinations and incomplete information on cataract subtypes. Therefore, it would be 
valuable in future studies to include regular and standardized eye examinations to enable 
better comparability between studies and to also include information on the grade and 
subtypes of cataract.  
 
In the future, studies could also examine dietary and lifestyle patterns rather than individual 
risk factors, which may give a more comprehensive picture of the association between diet 
and lifestyle-related factors and cataract prevention. Furthermore, studies taking into account 
gene-environment interactions are also needed. For example, genetics may influence how 
people respond to dietary antioxidants and physical activity.  
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